<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Chem Biol</journal-id><journal-id journal-id-type="iso-abbrev">ACS Chem. Biol</journal-id><journal-id journal-id-type="publisher-id">cb</journal-id><journal-id journal-id-type="coden">acbcct</journal-id><journal-title-group><journal-title>ACS Chemical Biology</journal-title></journal-title-group><issn pub-type="ppub">1554-8929</issn><issn pub-type="epub">1554-8937</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4201346</article-id><article-id pub-id-type="doi">10.1021/cb500327m</article-id><article-categories><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Structure-Guided Functional Characterization of Enediyne
Self-Sacrifice Resistance Proteins, CalU16 and CalU19</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Elshahawi</surname><given-names>Sherif
I.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Ramelot</surname><given-names>Theresa A.</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Seetharaman</surname><given-names>Jayaraman</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Chen</surname><given-names>Jing</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Singh</surname><given-names>Shanteri</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Yang</surname><given-names>Yunhuang</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Pederson</surname><given-names>Kari</given-names></name><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Kharel</surname><given-names>Madan
K.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes-1" ref-type="notes">&#x025a1;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Xiao</surname><given-names>Rong</given-names></name><xref rid="aff7" ref-type="aff">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Lew</surname><given-names>Scott</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath11"><name><surname>Yennamalli</surname><given-names>Ragothaman
M.</given-names></name><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath12"><name><surname>Miller</surname><given-names>Mitchell D.</given-names></name><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath13"><name><surname>Wang</surname><given-names>Fengbin</given-names></name><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath14"><name><surname>Tong</surname><given-names>Liang</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath15"><name><surname>Montelione</surname><given-names>Gaetano T.</given-names></name><xref rid="aff7" ref-type="aff">&#x02207;</xref><xref rid="aff9" ref-type="aff">&#x025c6;</xref></contrib><contrib contrib-type="author" id="ath16"><name><surname>Kennedy</surname><given-names>Michael
A.</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath17"><name><surname>Bingman</surname><given-names>Craig A.</given-names></name><xref rid="aff10" ref-type="aff">&#x000b6;</xref></contrib><contrib contrib-type="author" id="ath18"><name><surname>Zhu</surname><given-names>Haining</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath19"><name><surname>Phillips</surname><given-names>George N.</given-names><suffix>Jr.</suffix></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath20"><name><surname>Thorson</surname><given-names>Jon S.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Pharmaceutical Sciences, College of Pharmacy, <institution>University of Kentucky</institution>, Lexington, Kentucky 40536, <country>United States</country></aff><aff id="aff2"><label>&#x02021;</label>Center
for Pharmaceutical Research and Innovation (CPRI), College of Pharmacy, <institution>University of Kentucky</institution>, Lexington, Kentucky 40536, <country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label>Department
of Chemistry and Biochemistry, Northeast Structural Genomics Consortium, <institution>Miami University</institution>, Oxford, Ohio 45056, <country>United States</country></aff><aff id="aff4"><label>&#x02225;</label>Department
of Biological Sciences, Northeast Structural Genomics Consortium, <institution>Columbia University</institution>, New York, New York 10027, <country>United States</country></aff><aff id="aff5"><label>&#x022a5;</label>Department
of Molecular and Cellular Biochemistry &#x00026; Center for Structural
Biology, College of Medicine, <institution>University
of Kentucky</institution>, Lexington, Kentucky 40536, <country>United
States</country></aff><aff id="aff6"><label>#</label>Complex Carbohydrate
Research Center, Northeast Structural Genomics Consortium, <institution>University of Georgia</institution>, Athens, Georgia 30602, <country>United States</country></aff><aff id="aff7"><label>&#x02207;</label>Center
for Advanced Biotechnology and Medicine, Department of Molecular Biology
and Biochemistry, and Northeast Structural Genomics Consortium, Rutgers, <institution>The State University of New Jersey</institution>, Piscataway, New Jersey 08854, <country>United States</country></aff><aff id="aff8"><label>&#x025cb;</label>Department
of Biochemistry and Cell Biology, <institution>Rice University</institution>, Houston, Texas 77005, <country>United States</country></aff><aff id="aff9"><label>&#x025c6;</label>Department
of Biochemistry, Robert Wood Johnson Medical School, Rutgers, <institution>The State University of New Jersey</institution>, Piscataway, New Jersey 08854, <country>United States</country></aff><aff id="aff10"><label>&#x000b6;</label>Department
of Biochemistry, <institution>University of Wisconsin-Madison</institution>, Madison, Wisconsin 53706, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>jsthorson@uky.edu</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>georgep@rice.edu</email>.</corresp></author-notes><pub-date pub-type="pmc-release"><day>31</day><month>07</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>31</day><month>07</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>17</day><month>10</month><year>2014</year></pub-date><volume>9</volume><issue>10</issue><fpage>2347</fpage><lpage>2358</lpage><history><date date-type="received"><day>30</day><month>04</month><year>2014</year></date><date date-type="accepted"><day>31</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 American Chemical
Society</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American Chemical
Society</copyright-holder><license><license-p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">Terms of Use</ext-link></license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0006" id="ab-tgr1"/></p><p>Calicheamicin &#x003b3;<sub>1</sub><sup>I</sup> (<bold>1</bold>)
is an enediyne antitumor compound produced by <italic>Micromonospora
echinospora</italic> spp. calichensis, and its biosynthetic gene cluster
has been previously reported. Despite extensive analysis and biochemical
study, several genes in the biosynthetic gene cluster of <bold>1</bold> remain functionally unassigned. Using a structural genomics approach
and biochemical characterization, two proteins encoded by genes from
the <bold>1</bold> biosynthetic gene cluster assigned as &#x0201c;unknowns&#x0201d;,
CalU16 and CalU19, were characterized. Structure analysis revealed
that they possess the STeroidogenic Acute Regulatory protein related
lipid Transfer (START) domain known mainly to bind and transport lipids
and previously identified as the structural signature of the enediyne
self-resistance protein CalC. Subsequent study revealed <italic>calU16</italic> and <italic>calU19</italic> to confer resistance to <bold>1</bold>, and reminiscent of the prototype CalC, both CalU16 and CalU19 were
cleaved by <bold>1</bold><italic>in vitro.</italic> Through site-directed
mutagenesis and mass spectrometry, we identified the site of cleavage
in each protein and characterized their function in conferring resistance
against <bold>1</bold>. This report emphasizes the importance of structural
genomics as a powerful tool for the functional annotation of unknown
proteins.</p></abstract><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cb500327m</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cb-2014-00327m</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">The calicheamicins
are a prototype
of the naturally occurring 10-membered enediyne antitumor antibiotic
family and were first reported in 1989 as metabolites of <italic>Micromonospora
echinospora</italic> spp. calichensis.<sup><xref ref-type="bibr" rid="ref1">1</xref>&#x02212;<xref ref-type="bibr" rid="ref3">3</xref></sup> Members of this family
share a structurally conserved bicyclo[7.3.1]enediyne core, also often
referred to as the &#x0201c;warhead&#x0201d; as this structural unit
is central to the fundamental enediyne mechanism of action (Figure <xref rid="fig1" ref-type="fig">1</xref>A).<sup><xref ref-type="bibr" rid="ref4">4</xref>&#x02212;<xref ref-type="bibr" rid="ref6">6</xref></sup> In all family members, the enediyne core is strategically
decorated with a bioorthogonal &#x0201c;triggering&#x0201d; system and
specific appendages that enhance affinity to the metabolite&#x02019;s
target (DNA/RNA). The calicheamicin trigger system (and that of esperamicins,
shishijimicins, and namenamicins) is comprised of a unique trisulfide
that, upon reduction by bioreductants such as glutathione, induces
an intramolecular hetero-Michael addition at C-9 (Figure <xref rid="fig1" ref-type="fig">1</xref>B).<sup><xref ref-type="bibr" rid="ref7">7</xref>&#x02212;<xref ref-type="bibr" rid="ref9">9</xref></sup> The resulting fused enediyne core ring strain invokes
a spontaneous cycloaromatization reaction which proceeds via a highly
reactive diradical intermediate that is rapidly quenched by any suitable
hydrogen source.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> Calicheamicin&#x02019;s high affinity
for the minor groove of DNA, by virtue of its aryltetrasaccharide,
insures that the diradical species is quenched via hydrogen abstraction
from the backbone of opposing strands of dsDNA to form DNA radicals
that, in the presence of oxygen, result in facile double-strand scission.<sup><xref ref-type="bibr" rid="ref11">11</xref>&#x02212;<xref ref-type="bibr" rid="ref13">13</xref></sup> The study of calicheamicin&#x02019;s many fascinating architectural
and functional facets have led to numerous discoveries/advances in
chemistry,<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> enzymology,<sup><xref ref-type="bibr" rid="ref16">16</xref>&#x02212;<xref ref-type="bibr" rid="ref26">26</xref></sup> and anticancer drug development<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> over the past
three decades. Yet, while the gene cluster encoding for calicheamicin
biosynthesis was cloned from <italic>M. echinospora</italic> and sequenced
nearly a decade ago,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> there remain a number
of genes (&#x0223c;30%) within this locus annotated as &#x0201c;unknowns&#x0201d;
due to a lack of homologues and/or biochemical characterization of
corresponding gene products.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(A) Selected structures of naturally occurring
10-membered enediynes.
The &#x0201c;warhead&#x0201d; is highlighted in red. (B) Proposed mechanism
of cycloaromatization of <bold>1</bold> and its effect on DNA scission
and CalC self-sacrifice mechanism.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0001" id="gr1" position="float"/></fig><p>Herein, we describe the application of structural genomics
as a
basis for the functional characterization of two proteins encoded
by such &#x0201c;unknowns&#x0201d;&#x02014;CalU16 and CalU19. Specifically,
structure elucidation (via both NMR and X-ray crystallography) revealed
CalU16 to be a structural homologue of CalC, a protein previously
characterized as among the first reported enediyne &#x0201c;self-sacrifice&#x0201d;
resistance proteins.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Prompted by this structure-based
revelation, subsequent biochemical characterization of CalU16 and
its homologue CalU19 revealed both to serve in a similar capacity
wherein CalU19 also displayed the unprecedented ability to trigger
enediyne cycloaromatization in the absence of endogenous reducing
agents. Cumulatively, this work extends the body of work focused upon
understanding how bacteria construct and control highly reactive and
lethal metabolites and expands the number of known &#x0201c;self-sacrifice&#x0201d;
enediyne resistance proteins. This work also serves to illustrate
the impact of structure determination as a critical tool for the functional
annotation of unassigned genes.</p><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>CalU16
Structure and CalU19 Homology Model</title><p>Protein
Structure Initiative (PSI- Biology) employs a complementary combination
of NMR spectroscopy and/or X-ray crystallography to determine 3D-structures
of biologically relevant targets. The structure of CalU16 was solved
both by X-ray crystallography (Protein Database Bank (PDB: 4FPW)) and NMR (PDB: 2LUZ). The crystal structure
of CalU16 was determined at 2.50 &#x000c5; resolution, refined to an <italic>R</italic><sub>cryst</sub> and <italic>R</italic><sub>free</sub> of
24.1% and 28.2% (Table <xref rid="tbl1" ref-type="other">1</xref>), respectively, and
is comprised of two subunits in an asymmetric unit belonging to space
group <italic>P</italic>6<sub>1</sub> (Figure <xref rid="fig2" ref-type="fig">2</xref>). Of the 182 residues of CalU16, the first 4 residues, the last
2 residues, and a dynamic loop containing 19 residues (a.a. 141&#x02013;159)
from subunit A and 15 residues (a.a. 144&#x02013;158) from subunit
B were not modeled due to insufficient electron density. Structure
and quality statistics are given in Table <xref rid="tbl1" ref-type="other">1</xref>. The corresponding solution structure of CalU16 was determined by
multidimensional heteronuclear NMR spectroscopy (<xref rid="notes-2" ref-type="notes">Supporting Information Figures S1&#x02013;S3</xref>). Nearly complete <sup>1</sup>H, <sup>15</sup>N, and <sup>13</sup>C assignments were obtained
and structures were calculated from residual dipolar couplings (RDCs),
chemical shift-derived dihedral angle constraints, and Nuclear Overhauser
Effect (NOE)-derived distance constraints via standard protocols.
Structure and quality statistics are given in Table <xref rid="tbl2" ref-type="other">2</xref> for the ensemble of 20 lowest energy structures, indicating
the high quality of the structure. Intrinsic disorder was observed
for the first 6 residues, the last 3 residues, and 21 residues that
includes a loop and part of the following helix (a.a. 143&#x02013;163)
and is corroborated by a lack of long-range NOEs and low (&#x0003c;0.6) <sup>15</sup>N{<sup>1</sup>H} heteronuclear values (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S3</xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Structure of CalU16.
(A) Overlay of NMR (green) and monomers of
the crystal (brick- red) structures of CalU16. The <italic>N</italic>- and <italic>C</italic>-termini of the protein are labeled, while
the dynamic loop is colored yellow. (B) Monomer with secondary structural
elements labeled. The residues in the hydrophobic cavity are represented
as stick models. (C) B-factors for the C&#x003b1; atoms in the crystal
structure (left) and C&#x003b1; RMSD values from the NMR ensemble (right)
are mapped to the color and tube diameter of &#x0201c;putty&#x0201d;
traces showing the general agreement (correlation coefficient 0.559)
between the structures.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0002" id="gr2" position="float"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Summary of Crystal Parameters, Data
Collection, and Refinement Statistics<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">property</th><th style="border:none;" align="center">value</th></tr></thead><tbody><tr><td colspan="2" style="border:none;" align="left">Crystal Param.</td></tr><tr><td style="border:none;" align="left">space group</td><td style="border:none;" align="left"><italic>P</italic>6<sub>1</sub></td></tr><tr><td style="border:none;" align="left">molecules per asymmetric
unit</td><td style="border:none;" align="left">2</td></tr><tr><td style="border:none;" align="left"><italic>V</italic><sub>M</sub>&#x000a0;(&#x000c5;<sup>3</sup>&#x000a0;Da<sup>&#x02013;1</sup>)</td><td style="border:none;" align="left">2.95</td></tr><tr><td style="border:none;" align="left">unit-cell param. (&#x000c5;)</td><td style="border:none;" align="left">a = b&#x000a0;=&#x000a0;51.85, c&#x000a0;=&#x000a0;305.70</td></tr><tr><td colspan="2" style="border:none;" align="left">Data Collection Statistics</td></tr><tr><td style="border:none;" align="left">wavelength (&#x000c5;)</td><td style="border:none;" align="left">0.9790</td></tr><tr><td style="border:none;" align="left">resolution range (&#x000c5;)</td><td style="border:none;" align="left">50.00&#x02013;2.50 (2.59&#x02013;2.50)</td></tr><tr><td style="border:none;" align="left">no. of reflections (measured/unique)</td><td style="border:none;" align="left">236417/16051</td></tr><tr><td style="border:none;" align="left">completeness
(%)</td><td style="border:none;" align="left">99.9&#x000a0;(99.5)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>merge</sub><xref rid="t1fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">0.056&#x000a0;(0.169)</td></tr><tr><td style="border:none;" align="left">redundancy</td><td style="border:none;" align="left">14.8&#x000a0;(12.3)</td></tr><tr><td style="border:none;" align="left">mean&#x000a0;<italic>I</italic>/&#x003c3;&#x000a0;(I)</td><td style="border:none;" align="left">27.4&#x000a0;(10.4)</td></tr><tr><td colspan="2" style="border:none;" align="left">Refinement and Model
Statistics</td></tr><tr><td style="border:none;" align="left">resolution range (&#x000c5;)</td><td style="border:none;" align="left">44.91&#x02013;2.50</td></tr><tr><td style="border:none;" align="left">no.
of reflections (work/test)</td><td style="border:none;" align="left">15160/794</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>cryst</sub><xref rid="t1fn2" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">0.241&#x000a0;(0.325)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>free</sub><xref rid="t1fn3" ref-type="table-fn">d</xref></td><td style="border:none;" align="left">0.282&#x000a0;(0.371)</td></tr><tr><td style="border:none;" align="left">twin
operator</td><td style="border:none;" align="left">K, H, -L</td></tr><tr><td style="border:none;" align="left">twin fraction</td><td style="border:none;" align="left">0.50</td></tr><tr><td style="border:none;" align="left">RMSD bonds (&#x000c5;)</td><td style="border:none;" align="left">0.009</td></tr><tr><td style="border:none;" align="left">RMSD angles (deg)</td><td style="border:none;" align="left">1.453</td></tr><tr><td style="border:none;" align="left">B factor (protein/solvent) (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">53.8/50.9</td></tr><tr><td style="border:none;" align="left">no. of protein atoms</td><td style="border:none;" align="left">2497</td></tr><tr><td style="border:none;" align="left">no. of waters</td><td style="border:none;" align="left">128</td></tr><tr><td colspan="2" style="border:none;" align="left">Ramachandran Plot (%)<xref rid="t1fn4" ref-type="table-fn">e</xref></td></tr><tr><td style="border:none;" align="left">most favorable regions</td><td style="border:none;" align="left">91.3</td></tr><tr><td style="border:none;" align="left">allowed regions</td><td style="border:none;" align="left">5.8</td></tr><tr><td style="border:none;" align="left">disallowed regions</td><td style="border:none;" align="left">2.9</td></tr><tr><td colspan="2" style="border:none;" align="left">Global
Quality Scores (Raw/Z-Score)</td></tr><tr><td style="border:none;" align="left">Verify3D</td><td style="border:none;" align="left">0.4/&#x02013;1.0</td></tr><tr><td style="border:none;" align="left">ProsaII</td><td style="border:none;" align="left">0.5/&#x02013;0.6</td></tr><tr><td style="border:none;" align="left">Procheck
G factor (phi-psi)</td><td style="border:none;" align="left">&#x02013;0.6/&#x02013;2.0</td></tr><tr><td style="border:none;" align="left">Procheck G factor (all)</td><td style="border:none;" align="left">&#x02013;0.5/&#x02013;2.7</td></tr><tr><td style="border:none;" align="left">Molprobity
clash score</td><td style="border:none;" align="left">9.6/&#x02013;1.8</td></tr><tr><td style="border:none;" align="left">PDB ID</td><td style="border:none;" align="left">4FPW</td></tr></tbody></table><table-wrap-foot><fn id="tbl1-fn1"><label>a</label><p>Values in parentheses are for
the highest resolution shell.</p></fn><fn id="t1fn1"><label>b</label><p><italic>R</italic><sub>merge</sub> = &#x02211;<sub><italic>h</italic></sub> &#x02211;<sub><italic>i</italic></sub> | <italic>I</italic><sub><italic>i</italic></sub>(<italic>h</italic>) &#x02013; &#x027e8;<italic>I</italic>(<italic>h</italic>)&#x027e9;|/&#x02211;<sub><italic>h</italic></sub>&#x02211;<sub><italic>i</italic></sub><italic>I</italic><sub><italic>i</italic></sub>(<italic>h</italic>), where <italic>I</italic><sub>i</sub>(<italic>h</italic>) is the intensity of an individual
measurement of the reflection
and &#x027e8;<italic>I</italic>(<italic>h</italic>)&#x027e9; is the
mean intensity of the reflection.</p></fn><fn id="t1fn2"><label>c</label><p><italic>R</italic><sub>cryst</sub> = &#x02211;<sub><italic>h</italic></sub> ||<italic>F</italic><sub>obs</sub>| &#x02013; |<italic>F</italic><sub>calc</sub>||/&#x02211;<sub><italic>h</italic></sub> |<italic>F</italic><sub>obs</sub>|, where <italic>F</italic><sub>obs</sub> and <italic>F</italic><sub>calc</sub> are
the observed and calculated structure-factor amplitudes, respectively.</p></fn><fn id="t1fn3"><label>d</label><p><italic>R</italic><sub>free</sub> was calculated as <italic>R</italic><sub>cryst</sub> except that
it uses 10% of the reflection data omitted from refinement.</p></fn><fn id="t1fn4"><label>e</label><p>Calculated using Molprobity.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup></p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Summary of CalU16 Solution Structural
Statistics<xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">property</th><th style="border:none;" align="center">value</th></tr></thead><tbody><tr><td colspan="2" style="border:none;" align="left">Completeness of Resonance
Assignments<xref rid="t2fn2" ref-type="table-fn">b</xref></td></tr><tr><td style="border:none;" align="left">backbone (%)</td><td style="border:none;" align="left">98.3</td></tr><tr><td style="border:none;" align="left">side chain (%)</td><td style="border:none;" align="left">97.9</td></tr><tr><td style="border:none;" align="left">aromatic (%)</td><td style="border:none;" align="left">96.2</td></tr><tr><td style="border:none;" align="left">stereospecific methyl (%)</td><td style="border:none;" align="left">85.8</td></tr><tr><td colspan="2" style="border:none;" align="left">Conformationally
Restricting Constraints<xref rid="t2fn3" ref-type="table-fn">c</xref></td></tr><tr><td style="border:none;" align="left">distance constraints</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left"> total</td><td style="border:none;" align="left">2522</td></tr><tr><td style="padding-left: 2em;" align="left"> intraresidue
(<italic>i</italic> = <italic>j</italic>)</td><td style="border:none;" align="left">471</td></tr><tr><td style="padding-left: 2em;" align="left">&#x000a0;&#x000a0;sequential&#x000a0;(|<italic>I</italic>&#x000a0;&#x02013;&#x000a0;<italic>j</italic>|&#x000a0;=&#x000a0;1)</td><td style="border:none;" align="left">614</td></tr><tr><td style="padding-left: 2em;" align="left"> medium range (1&#x000a0;&#x0003c;&#x000a0;|<italic>i</italic>&#x000a0;&#x02013;&#x000a0;<italic>j</italic>|&#x000a0;&#x0003c;&#x000a0;5)</td><td style="border:none;" align="left">458</td></tr><tr><td style="padding-left: 2em;" align="left"> long-range (|<italic>i</italic>&#x000a0;&#x02013;&#x000a0;<italic>j</italic>|&#x000a0;&#x02265;&#x000a0;5)</td><td style="border:none;" align="left">979</td></tr><tr><td style="border:none;" align="left">dihedral angle constraints</td><td style="border:none;" align="left">222</td></tr><tr><td style="border:none;" align="left">hydrogen bond constraints</td><td style="border:none;" align="left">192</td></tr><tr><td style="border:none;" align="left">NH RDC constraints (gel&#x000a0;NH/NC&#x02032;)</td><td style="border:none;" align="left">75/59</td></tr><tr><td style="border:none;" align="left">no. of constraints
per residue</td><td style="border:none;" align="left">16.5</td></tr><tr><td style="border:none;" align="left">no. of long-range
constraints
per residue</td><td style="border:none;" align="left">6.0</td></tr><tr><td colspan="2" style="border:none;" align="left">Residual Constraint Violations<xref rid="t2fn3" ref-type="table-fn">c</xref></td></tr><tr><td colspan="2" align="left">avg. no. of distance
violations per structure</td></tr><tr><td style="padding-left: 2em;" align="left">0.1&#x02013;0.2
&#x000c5;</td><td style="border:none;" align="left">24.8</td></tr><tr><td style="padding-left: 2em;" align="left">0.2&#x02013;0.5&#x000a0;&#x000c5;</td><td style="border:none;" align="left">6.2</td></tr><tr><td style="padding-left: 2em;" align="left">&#x0003e; 0.5 &#x000c5;</td><td style="border:none;" align="left">0</td></tr><tr><td colspan="2" align="left">avg no. of dihedral
angle violations per structure</td></tr><tr><td style="padding-left: 2em;" align="left">1&#x02013;10&#x000b0;</td><td style="border:none;" align="left">17.8</td></tr><tr><td style="padding-left: 2em;" align="left">&#x0003e; 10&#x000b0;</td><td style="border:none;" align="left">0.2</td></tr><tr><td style="border:none;" align="left"> RDC <italic>Q</italic><sub>rmsd</sub> (gel&#x000a0;NH/NC&#x02032;)<xref rid="t2fn4" ref-type="table-fn">d</xref></td><td style="border:none;" align="left">0.4/0.3</td></tr><tr><td colspan="2" style="border:none;" align="left">Model Quality<xref rid="t2fn3" ref-type="table-fn">c</xref></td></tr><tr><td style="border:none;" align="left">RMSD backbone atoms (&#x000c5;)<xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">0.7</td></tr><tr><td style="border:none;" align="left">RMSD heavy atoms (&#x000c5;)<xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">1.2</td></tr><tr><td style="border:none;" align="left">RMSD
bond lengths (&#x000c5;)</td><td style="border:none;" align="left">0.018</td></tr><tr><td style="border:none;" align="left">RMSD bond angles (deg)</td><td style="border:none;" align="left">1.3</td></tr><tr><td style="border:none;" align="left">MolProbity
Ramachandran
statistics<xref rid="t2fn3" ref-type="table-fn">c</xref><sup>,</sup><xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">most favored regions (%)</td><td style="border:none;" align="left">94.6</td></tr><tr><td style="padding-left: 2em;" align="left">allowed
regions (%)</td><td style="border:none;" align="left">5.4</td></tr><tr><td style="padding-left: 2em;" align="left">disallowed regions (%)</td><td style="border:none;" align="left">0</td></tr><tr><td colspan="2" align="left">global quality scores
(Raw/<italic>Z</italic>-score)<xref rid="t2fn3" ref-type="table-fn">c</xref></td></tr><tr><td style="padding-left: 2em;" align="left">Verify3D</td><td style="border:none;" align="left">0.4/&#x02013;0.3</td></tr><tr><td style="padding-left: 2em;" align="left">ProsaII</td><td style="border:none;" align="left">0.5/&#x02013;0.6</td></tr><tr><td style="padding-left: 2em;" align="left">Procheck G factor (&#x003c6;&#x02013;&#x003c8;)<xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">&#x02013;0.4/ &#x02212;1.3</td></tr><tr><td style="padding-left: 2em;" align="left">Procheck G factor (all)<xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">&#x02013;0.3/&#x02013;2.0</td></tr><tr><td style="padding-left: 2em;" align="left">MolProbity clash score</td><td style="border:none;" align="left">16.0/&#x02013;1.2</td></tr><tr><td style="border:none;" align="left">RPF
scores<xref rid="t2fn6" ref-type="table-fn">f</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">recall/precision</td><td style="border:none;" align="left">0.98</td></tr><tr><td style="padding-left: 2em;" align="left">F-measure/DP-score</td><td style="border:none;" align="left">0.94</td></tr><tr><td colspan="2" style="border:none;" align="left">Model Contents</td></tr><tr><td style="padding-left: 2em;" align="left">ordered residue range<xref rid="t2fn5" ref-type="table-fn">e</xref></td><td style="border:none;" align="left">7&#x02013;65, 71&#x02013;89, 95&#x02013;140, 161&#x02013;179</td></tr><tr><td style="border:none;" align="left">BMRB accession no.</td><td style="border:none;" align="left">18547</td></tr><tr><td style="border:none;" align="left">PDB ID</td><td style="border:none;" align="left">2LUZ</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Structural statistics computed for
the ensemble of 20 deposited structures.</p></fn><fn id="t2fn2"><label>b</label><p>Computed using AVS software from
the expected number of resonances, excluding: highly exchangeable
protons (N-terminal, Lys, and Arg amino groups, hydroxyls of Ser,
Thr, Tyr), carboxyls of Asp and Glu, nonprotonated aromatic carbons,
for residues 1&#x02013;182.</p></fn><fn id="t2fn3"><label>c</label><p>Calculated using PSVS 1.4. Average
distance violations were calculated using the sum over <italic>r</italic><sup>&#x02013;6</sup>.</p></fn><fn id="t2fn4"><label>d</label><p>RDC
goodness-of-fit quality factor <italic>Q</italic><sub>rmsd</sub> determined
using PALES.</p></fn><fn id="t2fn5"><label>e</label><p>Based on ordered
residue ranges
[S(&#x003c6;) + S(&#x003c8;) &#x0003e; 1.8].</p></fn><fn id="t2fn6"><label>f</label><p>RPF scores reflecting the goodness-of-fit
of the final ensemble of structures (including disordered residues)
to the NOESY data and resonance assignments.</p></fn></table-wrap-foot></table-wrap><p>Superposition of the CalU16 solution structure with
individual
subunits of the crystal structure reveals a rmsd of 0.88 &#x000c5;, indicating
that the structures are quite similar. The major difference between
the two structures is the absence of the previously mentioned dynamic
loop region (residues 141&#x02013;159) in the crystal structure (Figure <xref rid="fig2" ref-type="fig">2</xref>). Interestingly, the crystal structure of CalU16
contains two subunits in the asymmetric unit related by 2-fold noncrystallographic
symmetry, with a small contact interface (calculated to be &#x0223c;530
&#x000c5;<sup>2</sup> by PISA).<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Based on
analytical static light scattering in-line (<xref rid="notes-2" ref-type="notes">Supporting
Information Figure S4</xref>) with gel filtration chromatography and
NMR correlation time estimates, CalU16 exists as a monomer in solution.
The final difference map also reveals an additional long tubular feature
in hydrophobic pocket, perhaps representing a bound unknown <italic>E. coli</italic> metabolite carried through the purification procedure
(<xref rid="notes-2" ref-type="notes">Supporting Information Figure S5</xref>).</p><p>The CalU16 monomer folds into a globular domain formed by four
&#x003b1;-helices and seven antiparallel &#x003b2;-strands in the order:
&#x003b2;1-&#x003b2;2-&#x003b1;1-&#x003b1;2-&#x003b2;3-&#x003b2;4-&#x003b2;5-&#x003b2;6-&#x003b2;7-&#x003b1;3-loop-&#x003b1;4
(Figure <xref rid="fig2" ref-type="fig">2</xref>). The domain exhibits a common tertiary
structure consisting of a helix-grip-fold, characteristic of STeroidogenic
Acute Regulatory protein related lipid Transfer (START) domains implicated
in possessing a hydrophobic cavity for ligand binding.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> The hydrophobic cavity in CalU16 spans the entire length of CalU16,
formed by seven &#x003b2;-strands and three helices, &#x003b1;1, &#x003b1;2,
and &#x003b1;3, encompassing residues Ile24, Ile26, Val37, Trp38, Ile47,
Trp50, Phe51, Ile52, Phe64, Leu66, Leu83, Ile74, Ile85, Trp87, Val97,
Leu99, Leu101, Leu110, Leu112, Val125, Trp129, Leu133, Leu136, and
Ile140 (Figure <xref rid="fig2" ref-type="fig">2</xref>). In addition to the START
domain core, the fourth helix (&#x003b1;4) of CalU16 contributes an
additional structural unit. Such extra secondary structural elements
are common upon START domain members where they contribute to a range
of structural/functional roles.<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref32">32</xref></sup></p><p>CalU19 is another
protein of unknown function encoded by a gene
in the calicheamicin gene cluster, which displays 42% sequence identity
to CalU16 (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S6</xref>). A CalU16-based homology model of CalU19, generated using SWISS-MODEL
also highlights the presence of a signature hydrophobic core consistent
with START domain family members, implicating a similar function (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S7</xref>).</p></sec><sec id="sec2.2"><title>Structurally-Related
Proteins</title><p>A structure-based similarity
search of CalU16 using DaliLite server<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> and PDBeFold<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> returned &#x0003e;100 hits
that
share close structural similarity. Figure <xref rid="fig3" ref-type="fig">3</xref> and <xref rid="notes-2" ref-type="notes">Supporting Information Table S1</xref> summarize
a small selection of functionally characterized structural homologues
of CalU16 (Figure <xref rid="fig3" ref-type="fig">3</xref>A). Among these is CalC
(PDB: 2L65)
(Figure <xref rid="fig3" ref-type="fig">3</xref>B), the prototype calicheamicin self-sacrifice
resistance protein encoded by the gene <italic>calC</italic> from
the same biosynthetic gene cluster as CalU16.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> In addition, three structures (Figure <xref rid="fig3" ref-type="fig">3</xref>C&#x02013;E)
associated with other natural product biosynthetic pathways were identified.
Specifically, TcmN Aro/Cyc (PDB: 3TVQ) is a polyketide aromatase/cyclase (Figure <xref rid="fig3" ref-type="fig">3</xref>C) involved in the regiospecific cyclization of
tetracenomycin,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Hyp-1 (PDB: 3IE5) is involved in
the formation of hypericin (Figure <xref rid="fig3" ref-type="fig">3</xref>D),<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> while NCS (PDB: 2VQ5) is involved in the biosynthesis of (<italic>S</italic>)-norcoclaurine (Figure <xref rid="fig3" ref-type="fig">3</xref>E).<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> Other representative structural homologues identified
include plant allergen Bet v1-J (PDB: 4A8U),<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> abscisic
acid receptor (PDB: 4N0G),<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> cytokinin-specific binding protein
(PDB: 2FLH),<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> and major celery allergen protein (PDB: 2BK0) (<xref rid="notes-2" ref-type="notes">Supporting Information Table S1</xref>).<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> A structural alignment of CalU16 with these homologues highlights
the striking conservation of the core structural fold, which contributes
to the binding site for a structurally diverse array of ligands including
steroids, lipids, hormones, and polyketides. However, a clear structural
difference in CalU16 is the presence of an additional helical region
near the residues 160&#x02013;180 (&#x003b1;4 helix as shown in Figure <xref rid="fig2" ref-type="fig">2</xref>B). While this extra helix is not observed in the
other homologues of known function, two functionally uncharacterized
CalU16 structural homologues also have this helix (PDB: 2NN5 and 2K5G).<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> Despite the plethora of available sequences and structures,<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref44">44</xref></sup> START domain structure/sequence alone remains insufficient to assign
function for newly discovered family members. Thus, additional structures
and parallel biochemical characterization are needed to establish
broader structure&#x02013;activity relationships of START domain proteins.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>CalU16
structural homologues. (A) CalU16 (PDB: 4FPW); (B) CalC (PDB: 2L65), calicheamicin
resistance protein; (C) TcmN Aro/Cyc (in complex with <italic>trans</italic>-dihydroquercetin; PDB: 3TVQ) involved in the biosynthesis of tetracenomycin; (D)
Hyp-1 (in complex with ethylene glycol; PDB: 3IE5) involved in the
biosynthesis of hypericin; (E) NCS (in complex with hydroxybenzaldehyde;
PDB: 2VQ5) involved
in the biosynthesis of norcoclaurine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0003" id="gr3" position="float"/></fig></sec><sec id="sec2.3"><title>Heterologous Expression of <italic>calU16</italic> or <italic>calU19</italic> in <italic>E. coli</italic> Confers Resistance to
Calicheamicin</title><p>Our initial cloning of the <bold>1</bold> biosynthetic
gene cluster was facilitated by employing a selection for <bold>1</bold> resistance using a <italic>M. echinospora</italic> cosmid library
in <italic>E. coli.</italic>(<xref ref-type="bibr" rid="ref16">16</xref>) From positive
cosmids identified, an iterative subcloning and selection process
ultimately led to the discovery of <italic>calC</italic> gene and
subsequent elucidation of the CalC mechanism.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> It is important to note that the initial screen for resistance genes
relied upon the native <italic>Micromonospora</italic> promoters for
heterologous expression in <italic>E. coli</italic>, and thus, <italic>calU16</italic> and <italic>calU19</italic> could have been missed
simply due to poor heterologous expression in <italic>E. coli.</italic> However, the ability of <italic>calC</italic> (and presumably other
self-sacrifice resistance protein encoding genes) to confer resistance
upon <italic>E. coli</italic> provides a convenient indicator for
putative function. As a preliminary assessment of potential CalU16/19
function, the genes encoding each protein were expressed in <italic>E. coli</italic> and the corresponding recombinant strains tested
for <bold>1</bold> resistance in a manner reminiscent to that previously
reported for CalC.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> To do so, <italic>calU16</italic> and <italic>calU19</italic> were cloned into pET28a
to provide pSECalU16-<italic>E. coli</italic> and pSECalU19-<italic>E. coli</italic>, respectively, and the corresponding heterologous
production levels of both CalU16 and CalU19 in <italic>E. coli</italic> were confirmed via SDS-PAGE to be comparable (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S8</xref>). A subsequent disc diffusion
assay was used to test for <bold>1</bold> resistance of pSECalU16-<italic>E. coli</italic>, pSECalU19-<italic>E. coli</italic>, pET28a-<italic>E. coli</italic> (an empty vector negative control), and pJB2011-<italic>E. coli</italic> (a <italic>calC</italic>-expressing positive control).<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Figure <xref rid="fig4" ref-type="fig">4</xref> illustrates
the rank order of <italic>in vivo</italic> resistance to be CalC &#x02248;
CalU19 &#x0003e; CalU16 with no resistance in the empty vector-containing
negative control. Consistent with this qualitative assessment, the
determination of minimum inhibitory concentration (MIC) (Table <xref rid="tbl3" ref-type="other">3</xref>, <xref rid="notes-2" ref-type="notes">Supporting Information Figure
S9</xref>), revealed both pJB2011-<italic>E. coli</italic> and pSECalU19-<italic>E. coli</italic> to be 330-fold more tolerant to <bold>1</bold> than
the pET28a-<italic>E. coli</italic> empty vector control while pSECalU16-<italic>E. coli</italic> was 80-fold more resistant than the control strain.
Importantly, this supports the contention that CalU16/19 function
in a manner similar to CalC. To further confirm that the <bold>1</bold>-resistance pattern of CalC, CalU16, and CalU19 is specific and not
an artifact related to general proteins encoded by genes in the calicheamicin
gene cluster, an identical study using the unknown-encoding gene <italic>calU17</italic> revealed no resistance toward <bold>1</bold> (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S10</xref>). It is also
important to note that <bold>1</bold> does not indiscriminately cleave
other proteins such as bovine serum albumin, illustrating the importance
of the START domain hydrophobic core for enediyne binding and functional
enediyne resistance.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup></p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>CalU16 and CalU19 assays.
Serial disc dilutions of <bold>1</bold> against (A) pSE28a-<italic>E. coli</italic> (control), (B) pSECalU16-<italic>E. coli</italic> (CalU16), (C) pSECalU19-<italic>E. coli</italic> (CalU19), (D) pJB2011-<italic>E. coli</italic> (CalC). Amount of <bold>1</bold> on discs 1&#x02013;6
are 10 &#x003bc;g, 1 &#x003bc;g, 100 ng,
50 ng, 10 ng, and 1 ng, respectively. Coomassie-stained 8&#x02013;12%
SDS-PAGE gradient gel of (E) CalU16 and (F) CalU19 in the presence
of DTT (lane 1), <bold>1</bold> (lane 2), and DTT and <bold>1</bold> (lane 3).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0004" id="gr4" position="float"/></fig><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Minimum
Inhibitory Concentration of
Strains Used in This Study Against <bold>1</bold></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">strain</th><th style="border:none;" align="center">MIC (&#x003bc;M)</th></tr></thead><tbody><tr><td style="border:none;" align="left">pSE28a-<italic>E. coli</italic></td><td style="border:none;" align="left">0.036</td></tr><tr><td style="border:none;" align="left">pSECalU16-<italic>E.
coli</italic></td><td style="border:none;" align="left">3</td></tr><tr><td style="border:none;" align="left">pSECalU19-<italic>E. coli</italic></td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">pJB2011-<italic>E. coli</italic></td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">pSEU16G128V-<italic>E.&#x000a0;coli</italic></td><td style="border:none;" align="left">0.36</td></tr><tr><td style="border:none;" align="left">pSEU16G128R-<italic>E. coli</italic></td><td style="border:none;" align="left">0.18</td></tr><tr><td style="border:none;" align="left">pSEU16G142V-<italic>E. coli</italic></td><td style="border:none;" align="left">3</td></tr><tr><td style="border:none;" align="left">pSEU16G142R-<italic>E. coli</italic></td><td style="border:none;" align="left">3</td></tr><tr><td style="border:none;" align="left">pSEU19G177V-<italic>E. coli</italic></td><td style="border:none;" align="left">6</td></tr><tr><td style="border:none;" align="left">pSEU19G177R-<italic>E. coli</italic></td><td style="border:none;" align="left">0.36</td></tr><tr><td style="border:none;" align="left">pSEU19G181V-<italic>E. coli</italic></td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">pSEU19G191V-<italic>E. coli</italic></td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">pSEU19G196V-<italic>E. coli</italic></td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">pSEU19G206V-<italic>E.&#x000a0;coli</italic></td><td style="border:none;" align="left">12</td></tr></tbody></table></table-wrap></sec><sec id="sec2.4"><title>CalU16 Biochemical Characterization</title><p>The prototype self-sacrifice
protein CalC functions via binding calicheamicin and providing an
alternative hydrogen source for quenching the highly reactive diradical
species formed upon calicheamicin cycloaromatization. In competition
assays using the real-time fluorescence-based molecular break light
assay,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> CalC was found to out-compete
DNA for calicheamicin and thereby prevent calicheamicin-induced strand
scission. In the presence of CalC, the calicheamicin diradical species
abstracts the C<sub>&#x003b1;</sub> hydrogen of G113 to generate a protein
radical that, in the presence of oxygen, leads to proteolysis into
two distinct CalC fragments (Figure <xref rid="fig1" ref-type="fig">1</xref>B).<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Thus, a similar series of proteolysis experiments
were conducted to determine whether CalU16 utilizes an analogous mechanism.
Figure <xref rid="fig4" ref-type="fig">4</xref> highlights the outcome of this analysis
using <italic>N</italic>-His<sub>6</sub>-CalU16. Importantly, incubation
of CalU16 with <bold>1</bold> alone led to no reaction, incubation
of CalU16 and <bold>1</bold> in the presence of reducing agent (dithiothreitol,
DTT) led to the specific cleavage of CalU16 into two fragments of
estimated size 16 kDa and 6 kDa based upon SDS-PAGE (Figure <xref rid="fig4" ref-type="fig">4</xref>E). LC-MS/MS analysis of the tryptic digestion of
the isolated fragments identified two nontryptic peptides flanking
Gly128: <sup>101</sup>LSEEGDGTLLELEHATTSEQMLVEVG<sup>127</sup>V(&#x02212;NH<sub>2</sub>) and <sup>129</sup>WEMALDFLGMFI<sup>141</sup>R (see MS/MS spectra of the two peptides in <xref rid="notes-2" ref-type="notes">Supporting Information Figure S11</xref>). The first
peptide ends with a nontryptic residue <sup>127</sup>V with an amine
group (&#x02212;NH<sub>2</sub>) from the <sup>128</sup>Gly residue
attached. The second peptide starts with <sup>129</sup>W further supports
that Gly128 is likely the cleavage site due to hydrogen abstraction.
In addition, the LC-MS/MS data suggested <sup>142</sup>G as another
potential cleavage site, based upon a weak peptide signal [<sup>129</sup>WEMALDFLGMFI<sup>141</sup>R(&#x02212;NH<sub>2</sub>), ion score =24].
However, the corresponding peptide starting with <sup>143</sup>D was
not identified. Nevertheless, we included both Gly128 and Gly142 in
CalU16 as putative sites in the subsequent mutational study to further
determine which glycine is the critical point of hydrogen abstraction.</p><p>To elucidate the key CalU16 glycine residue that serves as the
putative hydrogen donor, four targeted CalU16 glycine mutants (G128V,
G128R, G142V, and G142R) were created and tested both <italic>in vivo</italic> and <italic>in vitro.</italic> Strains expressing CalU16&#x00394;G142
mutations (pSEU16G142V-<italic>E. coli</italic> and pSEU16G142R-<italic>E. coli</italic>) retained wtCalU16 (pSECalU16-<italic>E. coli</italic>) resistance levels to <bold>1</bold> while mutation of Gly128 (pSEU16G128V-<italic>E. coli</italic> and pSEU16G128R-<italic>E. coli</italic>) reduced
or abolished tolerance to <bold>1</bold> (Figure <xref rid="fig5" ref-type="fig">5</xref>, <xref rid="notes-2" ref-type="notes">Supporting Information Figure S12</xref>, Table <xref rid="tbl3" ref-type="other">3</xref>). Consistent with this, <bold>1</bold>-based proteolysis of <italic>N</italic>-His<sub>6</sub>-CalU16 mutant
proteins (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S13</xref>) revealed CalU16G142V and CalU16G142R to cleave in an identical
manner to wtCalU16 in the presence of <bold>1</bold> and DTT while
CalU16G128V and CalU16G128R were resistant to cleavage under identical
conditions. Cumulatively, this data is consistent with CalU16 Gly128
as the key hydrogen donor in self-sacrifice mechanism, reminiscent
of CalC Gly113, wherein cleavage of CalU16 (or CalC) inactivates <bold>1</bold> in a stoichiometric manner.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Site directed mutagenesis of CalU16 and
CalU19. Docking models
of (A) CalC (B) CalU16, and (C) CalU19 with mutated glycine residues
represented as spheres where colored Gly residues indicate cleavage
sites, wheat Gly residues indicate mutations that did not affect activity
and calicheamicin (<bold>1</bold>) is represented as a stick model.
Results of disc diffusion assay in CalU16 mutants (D) pSE28a-<italic>E. coli</italic> (control); (E) pSEU16G128V-<italic>E. coli</italic>; (F) pSEU16G128R-<italic>E. coli</italic>; (G) pSECalU16-<italic>E. coli</italic>; and CalU19 mutants (H) pSE28a-<italic>E. coli</italic> (control); (I) pSEU19G177V-<italic>E. coli</italic>; (J) pSEU19G177R-<italic>E. coli</italic>; (K) pSECalU19-<italic>E. coli</italic>. Amount
of <bold>1</bold> on discs 1&#x02013;6 are 10 &#x003bc;g, 1 &#x003bc;g,
100 ng, 50 ng, 10 ng, and 1 ng, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb-2014-00327m_0005" id="gr5" position="float"/></fig></sec><sec id="sec2.5"><title>CalU19 Biochemical Characterization</title><p>To determine whether
the CalU16 homologue CalU19 presents a <bold>1</bold> self-sacrifice
resistance function analogous to CalC and CalU16, the expressed <italic>N</italic>-His<sub>6</sub>-CalU19 was purified and incubated with <bold>1</bold> alone or in the presence of a reducing agent (DTT). In this
study, CalU19 was also cleaved into two fragments by <bold>1</bold> but, in stark contrast to CalC and CalU16, <bold>1</bold>-induced
CalU19 cleavage occurred even in the absence of the reducing agent
DTT (Figure <xref rid="fig4" ref-type="fig">4</xref>F). The estimated sizes of the
corresponding CalU19 fragments were &#x0223c;21 and 6 kDa based upon
SDS-PAGE (<xref rid="notes-2" ref-type="notes">Supporting Information Table S2</xref>). LC-MS/MS analysis of the chymotrypsin digestion of the isolated
fragments identified two nonchymotryptic peptides flanking Gly177: <sup>142</sup>RLTPSGDATVLELEHAPVPAEIIPNAAPGAWGIG<sup>176</sup>A(&#x02212;NH<sub>2</sub>) and <sup>178</sup>WEMGLVALDDYLAGTLPEGRAVD<sup>201</sup>W (see MS/MS spectra of the two peptides in <xref rid="notes-2" ref-type="notes">Supporting Information Figure S14</xref>). The first
peptide ends with a nonchymotryptic residue <sup>176</sup>A with an
amine group (&#x02212;NH<sub>2</sub>) from the <sup>177</sup>Gly residue
attached. The second peptide starts with <sup>178</sup>W further supports
that Gly177 is likely the cleavage site due to hydrogen abstraction.</p><p>To confirm the key CalU19 glycine residue, two targeted CalU19&#x00394;Gly177
mutants (G177V and G177R) were created and tested both <italic>in
vivo</italic> and <italic>in vitro.</italic> To rule out any other
possible glycine residues that might be involved in the protein cleavage,
four additional glycine residues (Gly181, Gly191, Gly196 and Gly206)
were mutated and the corresponding mutants tested in parallel. The <italic>E. coli</italic> strains expressing CalU19G181V, CalU19G191V, CalU19G196V,
CalU19G206V (pSEU19G181V-<italic>E. coli</italic>, pSEU19G191V-<italic>E. coli</italic>, pSEU19G196V-<italic>E. coli</italic>, and pSEU19G206V-<italic>E. coli</italic>, respectively) retained wtCalU19 (pSECalU19-<italic>E. coli</italic>) resistance levels to <bold>1</bold> while mutation
of Gly177 (pSEU19G177V-<italic>E. coli</italic> and pSEU19G177R-<italic>E. coli</italic>) reduced or abolished tolerance to <bold>1</bold> (Figure <xref rid="fig5" ref-type="fig">5</xref>, <xref rid="notes-2" ref-type="notes">Supporting
Information Figure S15</xref>, and Table <xref rid="tbl3" ref-type="other">3</xref>)
as depicted by disc diffusion and MIC assays. Consistent with this, <bold>1</bold>-based proteolysis of <italic>N</italic>-His<sub>6</sub>-CalU19
mutant proteins revealed CalU19G177V and CalU19G177R to be resistant
to cleavage when compared with wtCalU19 under identical conditions
(<xref rid="notes-2" ref-type="notes">Supporting Information Figure S16</xref>). In
aggregate, this data is consistent with CalU19 Gly177 as the key hydrogen
donor in the context of <bold>1</bold> inactivation and served as
a basis for modeling the interactions of <bold>1</bold> with CalU16
and CalU19. Notably, the modeled orientation of <bold>1</bold> bound
to CalU16 or CalU19 appears to be different from <bold>1</bold> with
CalC (Figure <xref rid="fig5" ref-type="fig">5</xref>A&#x02013;C) consistent with prior
observations that the late stage biosynthetic intermediates en route
to <bold>1</bold> bind the glycosyltransferases involved in <bold>1</bold> maturation via distinct orientations.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup></p><p>Distinct from CalC and CalU16, CalU19 functioned
in the absence
of a reducing agent&#x02013;implicating a residue within CalU19 as
a putative reductive activator of the process. CalU19 contains two
cysteines (Cys25 and Cys120) where the CalU19 homology model suggests
Cys25 to potentially be closer to the trisulfide of <bold>1</bold> in a ligand-bound model than Cys120 (estimated distance 14.80 &#x000c5;, <xref rid="notes-2" ref-type="notes">Supporting Information Figure S17</xref>). To test the
putative role of Cys25 and Cys120, the corresponding alanine mutants
were generated and tested <italic>in vivo</italic> and <italic>in
vitro.</italic> Surprisingly, no differences in DTT-dependence were
observed between wtCalU19, CalU19Cys25A, CalU19Cys120A and the double
mutant CalU19Cys25A/Cys120A (<xref rid="notes-2" ref-type="notes">Supporting Information
Figure S18</xref>), suggesting <bold>1</bold> activation via CalU19
occurs via a nonredox mechanism. Notably, cycloaromatized calicheamicin
&#x003b5; (Figure <xref rid="fig1" ref-type="fig">1</xref>B) was detected in all CalU19
proteolysis experiments (including those with the double mutant CalU19Cys25A/Cys120A),
indicating there is an alternative CalU19 contributor to trisulfide
reductive initiation event.</p></sec><sec id="sec2.6"><title>Enediyne Specificity of CalU16 and CalU19</title><p>To test whether
CalU16 and CalU19 confer resistance against other 10-membered enediynes, <italic>in vivo</italic> and <italic>in vitro</italic> studies similar to
those described in the previous sections were performed where <bold>1</bold> was substituted with dynemicin (<bold>2</bold>) or esperamicin
A<sub>1</sub> (<bold>3</bold>). CalU16 and CalU19 each failed to cause
any cross resistance against <bold>2</bold> or <bold>3</bold><italic>in vivo</italic> (<xref rid="notes-2" ref-type="notes">Supporting Information Figure
S19</xref>), and consistent with these observations, neither protein
could be cleaved via <bold>2</bold> or <bold>3</bold> in the absence
or presence of reducing agent (<xref rid="notes-2" ref-type="notes">Supporting Information
Figure S20</xref>). Thus, CalU16 and CalU19 appear to display enediyne
specificity similar to CalC.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup></p></sec><sec sec-type="conclusions" id="sec3"><title>Conclusions</title><p>High throughput sequencing and genomics
are powerful tools to implicate putative function but are still limited
by three primary liabilities: (i) functional misannotation due to
mistakes propagated throughout large sequence databases; (ii) functional
misannotation due to the fact that even highly homologous proteins
can present dramatically distinct mechanisms/functions; and (iii)
a lack of suitably characterized homologues within existing large
sequence databases.<sup><xref ref-type="bibr" rid="ref46">46</xref>&#x02212;<xref ref-type="bibr" rid="ref48">48</xref></sup> Structural genomics can augment the use of sequence
homology for functional annotation by presenting opportunities to
identify structural homologues even where sequence homology may be
too low to identify suitable homologues.<sup><xref ref-type="bibr" rid="ref49">49</xref>&#x02212;<xref ref-type="bibr" rid="ref51">51</xref></sup> The current
study highlights the power of structural genomics to inform putative
function as the basis for subsequent biochemical characterization/confirmation
and, in doing so, reveals two new enediyne self-sacrifice proteins
(CalU16 and CalU19) encoded by genes in the calicheamicin biosynthetic
gene cluster. The elucidation of these genes serve as potential new
genetic markers which, in conjunction with the signature minimal enediyne
PKS cassette, may facilitate future enediyne discovery via genome
mining.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p><p>While there exist many
natural product biosynthetic loci that also encode for more than one
resistance mechanism for the encoded natural product,<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> the encoded redundancy highlighted by the current study is uncommon
and may suggest discrete self-sacrifice proteins to contribute to
subtle distinctions in their localization and/or function. For example,
the predicted isoelectric point of CalC (10.16) is dramatically different
from CalU16 (4.24) or CalU19 (4.69) (<xref rid="notes-2" ref-type="notes">Supporting
Information Table S2</xref>) and is consistent with CalC&#x02019;s
demonstrated ability to bind DNA (the target of enediynes) under physiological
pH.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Under identical conditions, CalU16/U19
are predicted to possess an overall negative charge, which may contribute
to distinct intracellular localization and/or unique protein&#x02013;protein
interactions possibly including those proteins/enzymes involved in <bold>1</bold> biosynthesis.</p><p>The enediyne self-sacrifice genes and
corresponding encoded proteins
have been validated in the context of conferring enediyne resistance,
but it remains possible that such proteins or their proteolytic fragments
could also serve alternative roles in <italic>Micromonospora.</italic> For example, many members of the START domain family function as
molecular chaperones as exemplified by the Coq10 homologue CC1736,
responsible for transporting ubiquinone to or within the respiratory
chain complexes and contributes to dramatically higher biosynthetic
efficiency.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Although the precedent for
molecular chaperones in the context of the structurally related 9-membered
enediynes is well established,<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> it remains to be determined
whether such proteins play additional roles beyond stabilizing the
highly reactive 9-membered enediyne chromophore. Preliminary evidence,
based upon the location of the key glycines in CalC, CalU16, and CalU19,
suggest that CalC binds <bold>1</bold> in a manner distinct from CalU16/CalU19
which, in the context of a molecular chaperone model, suggests different
regions of the cargo would be accessible to putative associated partner
proteins (Figure <xref rid="fig5" ref-type="fig">5</xref>A&#x02013;C). While CalC homologues
lack apparent polyketide aromatase/cyclase TcmN Aro/Cyc catalytic
residues based upon sequence (<xref rid="notes-2" ref-type="notes">Supporting Information
Figure S21</xref>) and structural (<xref rid="notes-2" ref-type="notes">Supporting
Information Figure S22</xref>) alignments, this relationship raises
the intriguing possibility of CalC homologues as the long sought after
contributors to enediyne polyketide core folding/cyclization. Indeed,
the surface area of the hydrophobic cavities of CalU16 (3986 &#x000c5;<sup>2</sup>), CalC (3931 &#x000c5;<sup>2</sup>), and TcmN ARO/CYC (3655
&#x000c5;<sup>2</sup>) are similar (<xref rid="notes-2" ref-type="notes">Supporting Information
Figure S23</xref>), the latter of which accommodates large (&#x02264;C20)
linear polyketides.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Alternatively, certain
proteolytic fragments from CalC, CalU16, and/or CalU19 could also
potentially serve as intracellular signals of enediyne concentrations,
in a manner conceptually similar to the vancomycin- or &#x003b2;-lactam-inducible
three-component regulatory systems, where hydrolytic fragments of
the bacterial cell wall serve as key inducers.<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref></sup> Studies are underway to further probe whether the functions of START
domain congeners encoded by the calicheamicin gene cluster extend
beyond simple protection of host against these highly reactive and
toxic metabolites.</p></sec></sec><sec sec-type="methods" id="sec4"><title>Methods</title><sec id="sec4.1"><title>Strains, Materials,
and General Methods</title><p>All primers
(Integrated DNA Technology) and strains used in this study are summarized
in <xref rid="notes-2" ref-type="notes">Supporting Information Tables S3 and S4</xref>, respectively. <italic>M. echinospora</italic> strain LL6000 and
calicheamicin &#x003b3;<sub>1</sub><sup>I</sup> were graciously provided
by Pfizer. Dynemicin and esperamicin A<sub>1</sub> were generously
provided by Bristol-Myers Squibb. All other reagents and chemicals
were purchased from Sigma-Aldrich, unless otherwise stated. All protein
structures were illustrated using PyMOL.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Gene alignments and analyses were performed using Geneious Pro 5.0.3.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup></p></sec><sec id="sec4.2"><title>Parental Plasmids for Protein Production</title><p>For biochemical
characterization, genomic DNA was extracted from <italic>M. echinospora</italic> LL6000 using the InstaGene Matrix Kit (BioRad) following manufacturer&#x02019;s
protocol. Primers CalU16-NdeI-F/CalU16-<italic>Hin</italic>dIII-R,
CalU17-NdeI-F/CalU17-<italic>Hin</italic>dIII-R, and CalU19-NdeI-F/CalU19-<italic>Hin</italic>dIII-R (<xref rid="notes-2" ref-type="notes">Supporting Information Table
S3</xref>) were used to amplify each of <italic>calU16</italic>, <italic>calU17</italic>, and <italic>calU19</italic>, respectively. Amplification
was performed using the Advantage GC2 polymerase enzyme (Clontech)
and the following PCR conditions: initial denaturation at 95 &#x000b0;C
for 3 min; 25 cycles at 94 &#x000b0;C for 30 s, 65&#x02013;62 &#x000b0;C
for 30 s, 68 &#x000b0;C for 35 s; final extension temperature at 68 &#x000b0;C
for 5 min. Each PCR product was gel purified using the QIAquick gel
extraction kit (Qiagen). Restriction digestion with NdeI/<italic>Hin</italic>dIII (New Englands Biolabs, NEB) followed by ligation using T4 DNA
ligase (NEB) into a linearized dephosphorylated pET28a (Novagen) yielded
pSECalU16, pSECalU17, and pSECalU19 for <italic>calU16</italic>, <italic>calU17</italic>, and <italic>calU19</italic>, respectively. Each
plasmid was transformed into NEB DH5&#x003b1; chemically competent cells
(NEB). Plasmids were purified using QIAprep Minispin kit (Qiagen).
Each plasmid was verified by sequencing and subsequently transformed
into the expression host BL21 (DE3) competent cells (NEB) to yield
pSECalU16-<italic>E. coli</italic>, pSECalU17-<italic>E. coli,</italic> and pSECalU19-<italic>E. coli,</italic> respectively. For structural
studies, plasmid preparation, overproduction, and purification were
conducted following standard protocols of the Northeast Structural
Genomics Consortium (NESG) to produce a uniformly <sup>15</sup>N/<sup>13</sup>C-enriched and 5% biosynthetically directed <sup>13</sup>C (NC5)-labeled protein samples for NMR spectroscopy and selenomethionine
(Se-Met) labeled samples for X-ray crystallography and details can
be found in <xref rid="notes-2" ref-type="notes">Supporting Information Methods</xref>.<sup><xref ref-type="bibr" rid="ref60">60</xref>,<xref ref-type="bibr" rid="ref61">61</xref></sup> In brief, <italic>calU16</italic> was PCR
amplified from genomic DNA and cloned into NdeI/XhoI-digested pET15
expression vector (NESG Clone ID MiR12&#x02013;15.1; PSI:Biology Materials
Repository clone ID MeCD000597015, see <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://psimr.asu.edu/">http://psimr.asu.edu/</uri>) to encode for the corresponding N-terminally tagged (MGHHHHHHSHM)
fusion protein. The plasmid was transformed into codon-enhanced <italic>E. coli</italic> BL21 (DE3) pMGK cells for protein production. Additional
plasmids and protocols employed for protein overproduction and purification
for biochemical studies are described in the <xref rid="notes-2" ref-type="notes">Supporting
Information Methods</xref>.</p></sec><sec id="sec4.3"><title>Structure Determination of CalU16 by X-ray
Crystallography</title><p>Initial crystallization conditions for Se-Met
labeled CalU16 were
identified at the Hauptmann-Woodward Institute high-throughput screening
facility<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> and further optimized manually
by microbatch methods at 18 &#x000b0;C. The protein was mixed in a 1:1
ratio with the precipitant containing 2.9 M sodium malonate pH 6.5.
The crystals were cryo-protected by 10% (v/v) ethylene glycol and
2.6 M sodium malonate pH 6.5 prior to flash freezing in liquid nitrogen
for data collection at 100 K. A single crystal of Se-Met labeled protein
was used for data collection at a wavelength of 0.978 &#x000c5; and diffracted
to 2.5 &#x000c5; resolution. The data was collected at beamline X4A at
the National Synchrotron Light Source at Brookhaven National Laboratory,
and further processed and scaled using HKL-2000 (Table <xref rid="tbl1" ref-type="other">1</xref>).<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> Eight of the ten selenium
sites in the asymmetric unit were successfully located by the SHELXD<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> program for initial phasing. RESOLVE<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> was utilized for automated model building and
the model was further built by manual refitting with the program Coot.<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> The data were twinned, and a twin refinement
was performed. The refinement involved iterations of manual model-building
in Coot and Refmac.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> The quality of the
final structure was validated by PROCHECK.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> The diffraction images illustrate diffuse scattering perpendicular
to the 6<sub>1</sub> screw axis indicative of order/disorder (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S24</xref>). The effects
of the disorder are also evident in the data anisotropy where the
B-factor component along the 6<sub>1</sub> axis is less than half
of the B-factor in the perpendicular direction. The unmodeled disorder
leads to higher than expected R-factors and is likely contributing
to the lower percentage of residues in the Ramachandran favored regions
(Table <xref rid="tbl1" ref-type="other">1</xref>). The atomic coordinates and structure
factors have been deposited in the PDB (4FPW).</p></sec><sec id="sec4.4"><title>NMR Spectroscopy and Structure
Determination of CalU16</title><p>NMR data were collected at 25 &#x000b0;C
on [<italic>U</italic>-<sup>13</sup>C, <sup>15</sup>N]- and <italic>U</italic>-<sup>15</sup>N,
5% biosynthetically directed <sup>13</sup>C (NC5)-labeled samples
in 300 &#x003bc;L buffered solution (0.9 mM CalU16, 0.02% NaN<sub>3</sub>, 10 mM DTT, 5 mM CaCl<sub>2</sub>, 100 mM NaCl, 1&#x000d7; proteinase
inhibitors, 20 mM MES pH 6.5) in 5 mm Shigemi NMR tubes on a 600 MHz
Varian Inova spectrometer with a 5 mm HCN cold probe and a 850 MHz
Bruker Avance III NMR spectrometer equipped with a conventional 5
mm HCN probe. A description of NMR experiments and methods for structure
determination and refinement can be found in <xref rid="notes-2" ref-type="notes">Supporting
Information Methods</xref>. The protein was monomeric under the conditions
used in the NMR experiments based on analytical static light scattering
in-line with gel filtration chromatography and correlation time estimates
based on one-dimensional <sup>15</sup>N <italic>T</italic><sub>1</sub> and <italic>T</italic><sub>2</sub> relaxation data (estimated &#x003c4;<sub>c</sub> 12.1 ns, <xref rid="notes-2" ref-type="notes">Supporting Information Figure
S1</xref>). The assigned <sup>1</sup>H&#x02013;<sup>15</sup>N HSQC
spectrum is provided as <xref rid="notes-2" ref-type="notes">Supporting Information
Figure S2</xref>. Chemical shifts, NOESY peak lists, and raw FIDS
were deposited in the BioMagResDB (BMRB accession number 18547). The
final ensemble of 20 models and NMR resonance assignments were deposited
to the Protein Data Bank (PDB: 2LUZ).</p></sec><sec id="sec4.5"><title>Resistance Assays</title><p><italic>In vivo</italic> resistance
assays were performed using overnight cultures of the tested strain
diluted to OD<sub>600</sub> &#x0223c; 0.1 in molten LB agar supplemented
with final concentration of 30 &#x003bc;g mL<sup>&#x02013;1</sup> kanamycin
and 100 &#x003bc;M of isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside
(IPTG). The mixture was poured into Petri dishes and allowed to solidify.
A stock solution of <bold>1</bold> was prepared in methanol at a concentration
of 1 mg mL<sup>&#x02013;1</sup> and serial dilutions were prepared
such that the final concentrations tested ranged from 0.1 to 10 &#x003bc;g
&#x003bc;L<sup>&#x02013;1</sup>. These were applied to sterile discs
such that the final quantities of <bold>1</bold> on the discs were
1 ng, 10 ng, 50 ng, 100 ng, 1 &#x003bc;g, and 10 &#x003bc;g. The disks
were allowed to air-dry, and applied aseptically to the plates. All
plates were incubated at 37 &#x000b0;C for 14 h.</p></sec><sec id="sec4.6"><title>Protein Cleavage Assay</title><p>Final concentration of 1 &#x003bc;M
of each protein in 50 mM Tris pH 8.0 in the presence of 1 mol equiv
of <bold>1</bold> with and without 0.2 mM DTT in a final volume of
500 &#x003bc;L was allowed to incubate at 30 &#x000b0;C for 30 min. Reactions
were lyophilized and resuspended in 25 &#x003bc;L of 50 mM Tris, pH
8.0. Cleavage was analyzed by mixing with equal volume of 2&#x000d7;
sample buffer. A volume of 30 &#x003bc;L was analyzed by NuPAGE 4&#x02013;12%
Bis-Tris Gels (Life technologies) using protein ladder (Bio-Rad) as
size indicator.</p></sec><sec id="sec4.7"><title>Trypsin Digestion and Mass Analysis</title><p>A total of 4 &#x003bc;M
of each of CalU16 and CalU19 were added to 2 mol equiv of <bold>1</bold> in the presence of 0.2 mM DTT. Reactions were incubated at 30 &#x000b0;C
for 30 min. A fraction of each reaction was subjected to SDS-PAGE
to confirm completion of the reaction. For proteolytic digestion,
the protein bands were excised from SDS-PAGE gel, washed with 50 mM
ammonium bicarbonate, reduced with DTT, alkylated with iodoacetamide
(IAA), and subjected to trypsin (for CalU16) or chymotrypsin (for
CalU19) digestion at 37 &#x000b0;C for 16 h. Peptides resulting from
the proteolytic digestion were extracted from gel pieces and analyzed
by LC-MS/MS as previously described.<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> Briefly,
the information-dependent acquisition of LC-MS/MS data were acquired
using an LTQ Velos Orbitrap mass spectrometer (Thermo Fisher Scientific,
Waltham, MA) coupled with a Nano-LC Ultra/cHiPLC-nanoflex HPLC system
(Eksigent, Dublin, CA) through a nano-electrospray ionization source.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> The results were subjected using ProteomeDiscoverer
1.3 software (Thermo Fisher Scientific, Waltham, MA) and MASCOT server.
The cleavage sites were deduced from nonenzymatic peptides ending
with an amine group (&#x02212;NH<sub>2</sub>) from the Gly residue
attached to a nontrypsin or nonchymotrypsin digestion site.</p></sec><sec id="sec4.8"><title>Determination
of Minimum Inhibitory Concentrations (MICs)</title><p>Fourteen strains
created in this study (<xref rid="notes-2" ref-type="notes">Supporting
Information Table S4</xref>, strains 2&#x02013;15) were grown overnight
in LB supplemented with kanamycin 30 mg L<sup>&#x02013;1</sup>. Each
overnight culture was diluted to OD<sub>600</sub> &#x0223c; 0.1 using
an Overnight Express Autoinduction System 1 (Novagen) supplemented
with kanamycin 30 mg L<sup>&#x02013;1</sup>. Enediyne <bold>1</bold> was serially diluted 1:2 in DMSO such that the final concentrations
ranged from 2.4 &#x003bc;M to 4.5 nM for pSE28a-<italic>E. coli</italic> and from 12 &#x003bc;M to 22 nM for all other strains. Ampicillin
and kanamycin were used as positive and negative controls, respectively.
All plates were incubated for 18 h at 37 &#x000b0;C at 250 rpm. The residual
metabolic activity was monitored based on the irreversible reduction
of resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide, blue) to resorufin
(7-hydroxy-3H-phenoxazin-3-one, pink). For this assay, 10 &#x003bc;L
of resazurin (final concentration 100 &#x003bc;M) was added to each
well and allowed to incubate at 37 &#x000b0;C with shaking at 250 rpm
for 1 h to allow viable cells to convert resazurin to resorufin. The
well with the minimum concentration of <bold>1</bold> that did not
display bacterial growth but did display a red color after incubation
with resazurin was recorded as the MIC of that strain (<xref rid="notes-2" ref-type="notes">Supporting Information Figure S9</xref>; Table <xref rid="tbl3" ref-type="other">3</xref>).</p></sec></sec></body><back><notes id="notes-2" notes-type="si"><title>Supporting Information Available</title><p>Additional
protocols and methods,
supplemental figures, and supplemental tables. This material is available
free of charge <italic>via</italic> the Internet at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb500327m_si_001.pdf"><caption><p>cb500327m_si_001.pdf</p></caption></media></supplementary-material></sec><notes id="notes-1"><title>Author Present Address</title><p><sup>&#x025a1;</sup> School
of Pharmacy and Health Profession, University
of Maryland Eastern Shore, Princess Anne, Maryland 21853,
U.S.A.</p></notes><notes id="notes-3" notes-type="conflict-of-interest"><p>The authors
declare the following competing financial interest(s): J.S.T. is a
co-founder of Centrose (Madison, WI).</p></notes><ack><title>Acknowledgments</title><p>This work
was supported by the National Institutes of Health
(NIH) grants CA84374 (to J.S.T.), U01GM098248 (to G.N.P.), the National
Center for Advancing Translational Sciences (UL1TR000117), a NIH PSI
grant (U54-GM094597 to M.A.K. and G.T.M.) and the BioXFEL Science
and Technology Center under National Science Foundation Grant No.
1231306. Enediynes for this study were generously provided by Pfizer
(calicheamicin) and Bristol-Myers-Squibb (esperamicin and dynemicin).
Proteomics analyses were conducted by the University of Kentucky Proteomics
Core that is partially supported by grants from the National Institute
of General Medical Sciences (P20GM103486), the National Cancer Institute
(P30CA177558) and equipment acquired via a grant from National Center
for Research Resources (1S10RR029127 to H.Z.). Protein NMR data collection
was conducted at the Ohio Biomedicine Center of Excellence in Structural
Biology and Metabolomics (Miami University). We thank Dr. J. Prestgard,
Dr. T. Acton, and Dr. J. Everett at the Northeast Structural Genomics
Consortium for technical assistance and J. Schwanof and R. Abramowitz
for data collection assistance at beamline X4A, NSLS.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Maiese</surname><given-names>W. M.</given-names></name>; <name><surname>Lechevalier</surname><given-names>M. P.</given-names></name>; <name><surname>Lechevalier</surname><given-names>H. A.</given-names></name>; <name><surname>Korshalla</surname><given-names>J.</given-names></name>; <name><surname>Kuck</surname><given-names>N.</given-names></name>; <name><surname>Fantini</surname><given-names>A.</given-names></name>; <name><surname>Wildey</surname><given-names>M. J.</given-names></name>; <name><surname>Thomas</surname><given-names>J.</given-names></name>; <name><surname>Greenstein</surname><given-names>M.</given-names></name> (<year>1989</year>) <article-title>Calicheamicins, a novel family of antitumor antibiotics:
taxonomy, fermentation and biological properties</article-title>. <source>J. Antibiot. (Tokyo)</source>
<volume>42</volume>, <fpage>558</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">2722671</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Lee</surname><given-names>M. D.</given-names></name>; <name><surname>Manning</surname><given-names>J. K.</given-names></name>; <name><surname>Williams</surname><given-names>D. R.</given-names></name>; <name><surname>Kuck</surname><given-names>N. A.</given-names></name>; <name><surname>Testa</surname><given-names>R. T.</given-names></name>; <name><surname>Borders</surname><given-names>D. B.</given-names></name> (<year>1989</year>) <article-title>Calicheamicins,
a novel family of antitumor antibiotics.
3. Isolation, purification and characterization of calicheamicins
&#x003b2; 1Br, &#x003b3; 1Br, &#x003b1; 2I, &#x003b1; 3I, &#x003b2; 1I, &#x003b3;
1I, and &#x003b4; 1I</article-title>. <source>J. Antibiot. (Tokyo)</source>
<volume>42</volume>, <fpage>1070</fpage>&#x02013;<lpage>1087</lpage>.<pub-id pub-id-type="pmid">2753814</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Lee</surname><given-names>M. D.</given-names></name>; <name><surname>Dunne</surname><given-names>T. S.</given-names></name>; <name><surname>Chang</surname><given-names>C. C.</given-names></name>; <name><surname>Siegel</surname><given-names>M. M.</given-names></name>; <name><surname>Morton</surname><given-names>G. O.</given-names></name>; <name><surname>Ellestad</surname><given-names>G. A.</given-names></name>; <name><surname>McGahren</surname><given-names>W. J.</given-names></name>; <name><surname>Borders</surname><given-names>D. B.</given-names></name> (<year>1992</year>) <article-title>Calicheamicins,
a novel family of antitumor antibiotics. 4. Structure elucidation
of calicheamicins &#x003b2; 1Br, &#x003b3; 1Br, &#x003b1; 2I, &#x003b1; 3I,
&#x003b2; 1I, &#x003b3; 1I, and &#x003b4; 1I</article-title>. <source>J. Am.
Chem. Soc.</source>
<volume>114</volume>, <fpage>985</fpage>&#x02013;<lpage>997</lpage>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Thorson</surname><given-names>J.
S.</given-names></name>; <name><surname>Sievers</surname><given-names>E. L.</given-names></name>; <name><surname>Ahlert</surname><given-names>J.</given-names></name>; <name><surname>Shepard</surname><given-names>E.</given-names></name>; <name><surname>Whitwam</surname><given-names>R. E.</given-names></name>; <name><surname>Onwueme</surname><given-names>K. C.</given-names></name>; <name><surname>Ruppen</surname><given-names>M.</given-names></name> (<year>2000</year>) <article-title>Understanding and exploiting nature&#x02019;s
chemical arsenal: The past, present, and future of calicheamicin research</article-title>. <source>Curr. Pharm. Des.</source>
<volume>6</volume>, <fpage>1841</fpage>&#x02013;<lpage>1879</lpage>.<pub-id pub-id-type="pmid">11102565</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Galm</surname><given-names>U.</given-names></name>; <name><surname>Hager</surname><given-names>M. H.</given-names></name>; <name><surname>Van Lanen</surname><given-names>S. G.</given-names></name>; <name><surname>Ju</surname><given-names>J.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name>; <name><surname>Shen</surname><given-names>B.</given-names></name> (<year>2005</year>) <article-title>Antitumor
antibiotics: Bleomycin, enediynes, and mitomycin</article-title>. <source>Chem. Rev.</source>
<volume>105</volume>, <fpage>739</fpage>&#x02013;<lpage>758</lpage>.<pub-id pub-id-type="pmid">15700963</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Liang</surname><given-names>Z.-X.</given-names></name> (<year>2010</year>) <article-title>Complexity
and simplicity in the biosynthesis of enediyne natural products</article-title>. <source>Nat. Prod. Rep.</source>
<volume>27</volume>, <fpage>499</fpage>&#x02013;<lpage>528</lpage>.<pub-id pub-id-type="pmid">20336235</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>De
Voss</surname><given-names>J. J.</given-names></name>; <name><surname>Hangeland</surname><given-names>J. J.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name> (<year>1990</year>) <article-title>Characterization
of the <italic>in vitro</italic> cyclization chemistry of calicheamicin
and its relation to DNA cleavage</article-title>. <source>J. Am. Chem.
Soc.</source>
<volume>112</volume>, <fpage>4554</fpage>&#x02013;<lpage>4556</lpage>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Chatterjee</surname><given-names>M.</given-names></name>; <name><surname>Cramer</surname><given-names>K. D.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name> (<year>1993</year>) <article-title>Kinetic nature of thiol activation
in DNA cleavage by calicheamicin</article-title>. <source>J. Am. Chem.
Soc.</source>
<volume>115</volume>, <fpage>3374</fpage>&#x02013;<lpage>3375</lpage>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Myers</surname><given-names>A. G.</given-names></name>; <name><surname>Cohen</surname><given-names>S. B.</given-names></name>; <name><surname>Kwon</surname><given-names>B. M.</given-names></name> (<year>1994</year>) <article-title>A study
of the reaction of calicheamicin
&#x003b3; 1 with glutathione in the presence of double-stranded DNA</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>116</volume>, <fpage>1255</fpage>&#x02013;<lpage>1271</lpage>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Zein</surname><given-names>N.</given-names></name>; <name><surname>Sinha</surname><given-names>A. M.</given-names></name>; <name><surname>McGahren</surname><given-names>W. J.</given-names></name>; <name><surname>Ellestad</surname><given-names>G. A.</given-names></name> (<year>1988</year>) <article-title>Calicheamicin &#x003b3;
1I: An antitumor antibiotic that cleaves double-stranded DNA site
specifically</article-title>. <source>Science</source>
<volume>240</volume>, <fpage>1198</fpage>&#x02013;<lpage>1201</lpage>.<pub-id pub-id-type="pmid">3240341</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Zein</surname><given-names>N.</given-names></name>; <name><surname>Poncin</surname><given-names>M.</given-names></name>; <name><surname>Nilakantan</surname><given-names>R.</given-names></name>; <name><surname>Ellestad</surname><given-names>G. A.</given-names></name> (<year>1989</year>) <article-title>Calicheamicin &#x003b3;
1I and DNA: Molecular recognition process responsible for site-specificity</article-title>. <source>Science</source>
<volume>244</volume>, <fpage>697</fpage>&#x02013;<lpage>699</lpage>.<pub-id pub-id-type="pmid">2717946</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Mah</surname><given-names>S. C.</given-names></name>; <name><surname>Price</surname><given-names>M. A.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name>; <name><surname>Tullius</surname><given-names>T. D.</given-names></name> (<year>1994</year>) <article-title>Features of DNA
recognition for oriented binding and cleavage by calicheamicin</article-title>. <source>Tetrahedron</source>
<volume>50</volume>, <fpage>1361</fpage>&#x02013;<lpage>1378</lpage>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Biggins</surname><given-names>J. B.</given-names></name>; <name><surname>Prudent</surname><given-names>J. R.</given-names></name>; <name><surname>Marshall</surname><given-names>D. J.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2006</year>) <article-title>A continuous assay
for DNA cleavage using molecular break lights</article-title>. <source>Methods Mol. Biol.</source>
<volume>335</volume>, <fpage>83</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">16785622</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Danishefsky</surname><given-names>S. J.</given-names></name>; <name><surname>Shair</surname><given-names>M. D.</given-names></name> (<year>1996</year>) <article-title>Observations in the chemistry and biology of cyclic
enediyne antibiotics: Total syntheses of calicheamicin &#x003b3;<sub>1</sub><sup>I</sup> and dynemicin A</article-title>. <source>J. Org.
Chem.</source>
<volume>61</volume>, <fpage>16</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Nicolaou</surname><given-names>K.
C.</given-names></name>; <name><surname>Hale</surname><given-names>C. R. H.</given-names></name>; <name><surname>Nilewski</surname><given-names>C.</given-names></name> (<year>2012</year>) <article-title>A total synthesis trilogy: Calicheamicin
&#x003b3;1(I), Taxol, and brevetoxin A</article-title>. <source>Chem.
Rec.</source>
<volume>12</volume>, <fpage>407</fpage>&#x02013;<lpage>441</lpage>.<pub-id pub-id-type="pmid">22711588</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Ahlert</surname><given-names>J.</given-names></name>; <name><surname>Shepard</surname><given-names>E.</given-names></name>; <name><surname>Lomovskaya</surname><given-names>N.</given-names></name>; <name><surname>Zazopoulos</surname><given-names>E.</given-names></name>; <name><surname>Staffa</surname><given-names>A.</given-names></name>; <name><surname>Bachmann</surname><given-names>B. O.</given-names></name>; <name><surname>Huang</surname><given-names>K.</given-names></name>; <name><surname>Fonstein</surname><given-names>L.</given-names></name>; <name><surname>Czisny</surname><given-names>A.</given-names></name>; <name><surname>Whitwam</surname><given-names>R. E.</given-names></name>; <name><surname>Farnet</surname><given-names>C. M.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2002</year>) <article-title>The calicheamicin
gene cluster and its iterative type I enediyne PKS</article-title>. <source>Science</source>
<volume>297</volume>, <fpage>1173</fpage>&#x02013;<lpage>1176</lpage>.<pub-id pub-id-type="pmid">12183629</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Ahlert</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>Q.</given-names></name>; <name><surname>Wendt-Pienkowski</surname><given-names>E.</given-names></name>; <name><surname>Shen</surname><given-names>B.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2003</year>) <article-title>Rapid PCR
amplification of minimal
enediyne polyketide synthase cassettes leads to a predictive familial
classification model</article-title>. <source>Proc. Natl. Acad. Sci.
U.S.A.</source>
<volume>100</volume>, <fpage>11959</fpage>&#x02013;<lpage>11963</lpage>.<pub-id pub-id-type="pmid">14528002</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Biggins</surname><given-names>J.
B.</given-names></name>; <name><surname>Onwueme</surname><given-names>K. C.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2003</year>) <article-title>Resistance to enediyne antitumor
antibiotics by CalC self-sacrifice</article-title>. <source>Science</source>
<volume>301</volume>, <fpage>1537</fpage>&#x02013;<lpage>1541</lpage>.<pub-id pub-id-type="pmid">12970566</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Hager</surname><given-names>M. H.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Griffith</surname><given-names>B. R.</given-names></name>; <name><surname>Lee</surname><given-names>M. S.</given-names></name>; <name><surname>Hallenga</surname><given-names>K.</given-names></name>; <name><surname>Markley</surname><given-names>J. L.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2006</year>) <article-title>Structural insight
into the self-sacrifice mechanism of enediyne resistance</article-title>. <source>ACS Chem. Biol.</source>
<volume>1</volume>, <fpage>451</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">17168523</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Griffith</surname><given-names>B. R.</given-names></name>; <name><surname>Fu</surname><given-names>Q.</given-names></name>; <name><surname>Albermann</surname><given-names>C.</given-names></name>; <name><surname>Fu</surname><given-names>X.</given-names></name>; <name><surname>Lee</surname><given-names>I.-K.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2006</year>) <article-title>Exploiting the reversibility
of natural product glycosyltransferase-catalyzed reactions</article-title>. <source>Science</source>
<volume>313</volume>, <fpage>1291</fpage>&#x02013;<lpage>1294</lpage>.<pub-id pub-id-type="pmid">16946071</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Johnson</surname><given-names>H. D.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2008</year>) <article-title>Characterization of CalE10, the <italic>N</italic>-oxidase
involved in calicheamicin hydroxyaminosugar formation</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>130</volume>, <fpage>17662</fpage>&#x02013;<lpage>17663</lpage>.<pub-id pub-id-type="pmid">19055330</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Belecki</surname><given-names>K.</given-names></name>; <name><surname>Crawford</surname><given-names>J. M.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name> (<year>2009</year>) <article-title>Production of octaketide polyenes
by the calicheamicin polyketide synthase CalE8: Implications for the
biosynthesis of enediyne core structures</article-title>. <source>J.
Am. Chem. Soc.</source>
<volume>131</volume>, <fpage>12564</fpage>&#x02013;<lpage>12566</lpage>.<pub-id pub-id-type="pmid">19689130</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Horsman</surname><given-names>G. P.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name>; <name><surname>Shen</surname><given-names>B.</given-names></name> (<year>2010</year>) <article-title>Polyketide synthase
chemistry does not direct biosynthetic divergence between 9- and 10-membered
enediynes</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>107</volume>, <fpage>11331</fpage>&#x02013;<lpage>11335</lpage>.<pub-id pub-id-type="pmid">20534556</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Gantt</surname><given-names>R. W.</given-names></name>; <name><surname>Peltier-Pain</surname><given-names>P.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Zhou</surname><given-names>M.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name> (<year>2013</year>) <article-title>Broadening
the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>110</volume>, <fpage>7648</fpage>&#x02013;<lpage>7653</lpage>.<pub-id pub-id-type="pmid">23610417</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Belecki</surname><given-names>K.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name> (<year>2012</year>) <article-title>Environmental control of the calicheamicin polyketide
synthase leads to detection of a programmed octaketide and a proposal
for enediyne biosynthesis</article-title>. <source>Angew. Chem., Int.
Ed.</source>
<volume>51</volume>, <fpage>11316</fpage>&#x02013;<lpage>11319</lpage>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Belecki</surname><given-names>K.</given-names></name>; <name><surname>Townsend</surname><given-names>C. A.</given-names></name> (<year>2013</year>) <article-title>Biochemical determination
of enzyme-bound metabolites:
Preferential accumulation of a programmed octaketide on the enediyne
polyketide synthase CalE8</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>135</volume>, <fpage>14339</fpage>&#x02013;<lpage>14348</lpage>.<pub-id pub-id-type="pmid">24041368</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Ricart</surname><given-names>A. D.</given-names></name> (<year>2011</year>) <article-title>Antibody-drug
conjugates of calicheamicin derivative: Gemtuzumab Ozogamicin and
Inotuzumab Ozogamicin</article-title>. <source>Clin. Cancer Res.</source>
<volume>17</volume>, <fpage>6417</fpage>&#x02013;<lpage>6427</lpage>.<pub-id pub-id-type="pmid">22003069</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Trail</surname><given-names>P. A.</given-names></name> (<year>2013</year>) <article-title>Antibody
drug conjugates as cancer therapeutics</article-title>. <source>Antibodies</source>
<volume>2</volume>, <fpage>113</fpage>&#x02013;<lpage>129</lpage>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Henrick</surname><given-names>K.</given-names></name> (<year>2007</year>) <article-title>Inference of macromolecular
assemblies from crystalline
state</article-title>. <source>J. Mol. Biol.</source>
<volume>372</volume>, <fpage>774</fpage>&#x02013;<lpage>797</lpage>.<pub-id pub-id-type="pmid">17681537</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Iyer</surname><given-names>L. M.</given-names></name>; <name><surname>Koonin</surname><given-names>E. V.</given-names></name>; <name><surname>Aravind</surname><given-names>L.</given-names></name> (<year>2001</year>) <article-title>Adaptations of the
helix-grip fold
for ligand binding and catalysis in the START domain superfamily</article-title>. <source>Proteins</source>
<volume>43</volume>, <fpage>134</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">11276083</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Thorsell</surname><given-names>A.-G.</given-names></name>; <name><surname>Lee</surname><given-names>W. H.</given-names></name>; <name><surname>Persson</surname><given-names>C.</given-names></name>; <name><surname>Siponen</surname><given-names>M. I.</given-names></name>; <name><surname>Nilsson</surname><given-names>M.</given-names></name>; <name><surname>Busam</surname><given-names>R. D.</given-names></name>; <name><surname>Kotenyova</surname><given-names>T.</given-names></name>; <name><surname>Sch&#x000fc;ler</surname><given-names>H.</given-names></name>; <name><surname>Lehti&#x000f6;</surname><given-names>L.</given-names></name> (<year>2011</year>) <article-title>Comparative structural analysis of lipid binding START
domains</article-title>. <source>PloS One</source>
<volume>6</volume>, <fpage>e19521</fpage>.<pub-id pub-id-type="pmid">21738568</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Alpy</surname><given-names>F.</given-names></name>; <name><surname>Tomasetto</surname><given-names>C.</given-names></name> (<year>2005</year>) <article-title>Give lipids a START: The StAR-related lipid transfer
(START) domain in mammals</article-title>. <source>J. Cell Sci.</source>
<volume>118</volume>, <fpage>2791</fpage>&#x02013;<lpage>2801</lpage>.<pub-id pub-id-type="pmid">15976441</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Holm</surname><given-names>L.</given-names></name>; <name><surname>Rosenstr&#x000f6;m</surname><given-names>P.</given-names></name> (<year>2010</year>) <article-title>Dali server:
Conservation mapping in 3D</article-title>. <source>Nucleic Acids Res.</source>
<volume>38</volume>, <fpage>W545</fpage>&#x02013;<lpage>549</lpage>.<pub-id pub-id-type="pmid">20457744</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Henrick</surname><given-names>K.</given-names></name> (<year>2004</year>) <article-title>Secondary-structure
matching (SSM), a new tool for
fast protein structure alignment in three dimensions</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>60</volume>, <fpage>2256</fpage>&#x02013;<lpage>2268</lpage>.<pub-id pub-id-type="pmid">15572779</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Ames</surname><given-names>B. D.</given-names></name>; <name><surname>Korman</surname><given-names>T. P.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Smith</surname><given-names>P.</given-names></name>; <name><surname>Vu</surname><given-names>T.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>; <name><surname>Tsai</surname><given-names>S.-C.</given-names></name> (<year>2008</year>) <article-title>Crystal
structure and functional
analysis of tetracenomycin ARO/CYC: Implications for cyclization specificity
of aromatic polyketides</article-title>. <source>Proc. Natl. Acad. Sci.
U.S.A.</source>
<volume>105</volume>, <fpage>5349</fpage>&#x02013;<lpage>5354</lpage>.<pub-id pub-id-type="pmid">18388203</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Michalska</surname><given-names>K.</given-names></name>; <name><surname>Fernandes</surname><given-names>H.</given-names></name>; <name><surname>Sikorski</surname><given-names>M.</given-names></name>; <name><surname>Jaskolski</surname><given-names>M.</given-names></name> (<year>2010</year>) <article-title>Crystal structure
of Hyp-1, a St. John&#x02019;s Wort protein implicated in the biosynthesis
of hypericin</article-title>. <source>J. Struct. Biol.</source>
<volume>169</volume>, <fpage>161</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">19853038</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Ilari</surname><given-names>A.</given-names></name>; <name><surname>Franceschini</surname><given-names>S.</given-names></name>; <name><surname>Bonamore</surname><given-names>A.</given-names></name>; <name><surname>Arenghi</surname><given-names>F.</given-names></name>; <name><surname>Botta</surname><given-names>B.</given-names></name>; <name><surname>Macone</surname><given-names>A.</given-names></name>; <name><surname>Pasquo</surname><given-names>A.</given-names></name>; <name><surname>Bellucci</surname><given-names>L.</given-names></name>; <name><surname>Boffi</surname><given-names>A.</given-names></name> (<year>2009</year>) <article-title>Structural
basis of enzymatic (<italic>S</italic>)-norcoclaurine biosynthesis</article-title>. <source>J. Biol. Chem.</source>
<volume>284</volume>, <fpage>897</fpage>&#x02013;<lpage>904</lpage>.<pub-id pub-id-type="pmid">19004827</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Kofler</surname><given-names>S.</given-names></name>; <name><surname>Asam</surname><given-names>C.</given-names></name>; <name><surname>Eckhard</surname><given-names>U.</given-names></name>; <name><surname>Wallner</surname><given-names>M.</given-names></name>; <name><surname>Ferreira</surname><given-names>F.</given-names></name>; <name><surname>Brandstetter</surname><given-names>H.</given-names></name> (<year>2012</year>) <article-title>Crystallographically mapped ligand binding differs
in high and low IgE binding isoforms of birch pollen allergen bet
v 1</article-title>. <source>J. Mol. Biol.</source>
<volume>422</volume>, <fpage>109</fpage>&#x02013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">22634284</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Sheng</surname><given-names>X.</given-names></name>; <name><surname>Yan</surname><given-names>C.</given-names></name>; <name><surname>Zhou</surname><given-names>R.</given-names></name>; <name><surname>Hang</surname><given-names>J.</given-names></name>; <name><surname>Yin</surname><given-names>P.</given-names></name>; <name><surname>Yan</surname><given-names>N.</given-names></name> (<year>2013</year>) <article-title>Molecular basis for
the selective and ABA-independent inhibition of PP2CA by PYL13</article-title>. <source>Cell Res.</source>
<volume>23</volume>, <fpage>1369</fpage>&#x02013;<lpage>1379</lpage>.<pub-id pub-id-type="pmid">24165892</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Pasternak</surname><given-names>O.</given-names></name>; <name><surname>Bujacz</surname><given-names>G. D.</given-names></name>; <name><surname>Fujimoto</surname><given-names>Y.</given-names></name>; <name><surname>Hashimoto</surname><given-names>Y.</given-names></name>; <name><surname>Jelen</surname><given-names>F.</given-names></name>; <name><surname>Otlewski</surname><given-names>J.</given-names></name>; <name><surname>Sikorski</surname><given-names>M. M.</given-names></name>; <name><surname>Jaskolski</surname><given-names>M.</given-names></name> (<year>2006</year>) <article-title>Crystal structure
of <italic>Vigna radiata</italic> cytokinin-specific binding protein
in complex with zeatin</article-title>. <source>Plant Cell</source>
<volume>18</volume>, <fpage>2622</fpage>&#x02013;<lpage>2634</lpage>.<pub-id pub-id-type="pmid">16998071</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Schirmer</surname><given-names>T.</given-names></name>; <name><surname>Hoffimann-Sommergrube</surname><given-names>K.</given-names></name>; <name><surname>Susani</surname><given-names>M.</given-names></name>; <name><surname>Breiteneder</surname><given-names>H.</given-names></name>; <name><surname>Markovi&#x00107;-Housley</surname><given-names>Z.</given-names></name> (<year>2005</year>) <article-title>Crystal structure
of the major celery
allergen Api g 1: Molecular analysis of cross-reactivity</article-title>. <source>J. Mol. Biol.</source>
<volume>351</volume>, <fpage>1101</fpage>&#x02013;<lpage>1109</lpage>.<pub-id pub-id-type="pmid">16051263</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="undeclared" id="cit42"><person-group person-group-type="allauthors"><name><surname>Osipiuk</surname><given-names>J.</given-names></name>, <name><surname>Wu</surname><given-names>R.</given-names></name>, <name><surname>Moy</surname><given-names>S.</given-names></name>, <name><surname>Joachimiak</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>) <source>X-ray crystal structure
of conserved hypothetical protein EF_2215 from <inline-formula><italic>Enterococcus faecalis</italic></inline-formula></source>. PDB ID:
2NN5. Unpublished.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="undeclared" id="cit43"><person-group person-group-type="allauthors"><name><surname>Singarapu</surname><given-names>K.</given-names></name>, <name><surname>Eletsky</surname><given-names>A.</given-names></name>, <name><surname>Sathyamoorthy</surname><given-names>B.</given-names></name>, <name><surname>Sukumaran</surname><given-names>D.</given-names></name>, <name><surname>Wang</surname><given-names>D.</given-names></name>, <name><surname>Jiang</surname><given-names>M.</given-names></name>, <name><surname>Ciccosanti</surname><given-names>C.</given-names></name>, <name><surname>Xiao</surname><given-names>R.</given-names></name>, <name><surname>Liu</surname><given-names>J.</given-names></name>, <name><surname>Baran</surname><given-names>M. C.</given-names></name>, <name><surname>Swapna</surname><given-names>G.</given-names></name>, <name><surname>Acton</surname><given-names>T. B.</given-names></name>, <name><surname>Rost</surname><given-names>B.</given-names></name>, <name><surname>Montelione</surname><given-names>G. T.</given-names></name>, <name><surname>Szyperski</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>) <source>Solution NMR structure of protein encoded
by gene BPP1335
from <inline-formula><italic>Bordetella parapertussis</italic></inline-formula></source>. PDB ID: 2K5G. Unpublished.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Clark</surname><given-names>B. J.</given-names></name> (<year>2012</year>) <article-title>The mammalian
START domain protein family in lipid transport in health and disease</article-title>. <source>J. Endocrinol.</source>
<volume>212</volume>, <fpage>257</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">21965545</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Chang</surname><given-names>A.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Helmich</surname><given-names>K. E.</given-names></name>; <name><surname>Goff</surname><given-names>R. D.</given-names></name>; <name><surname>Bingman</surname><given-names>C. A.</given-names></name>; <name><surname>Thorson</surname><given-names>J. S.</given-names></name>; <name><surname>Phillips</surname><given-names>G. N.</given-names><suffix>Jr.</suffix></name> (<year>2011</year>) <article-title>Complete set
of glycosyltransferase structures in the calicheamicin biosynthetic
pathway reveals the origin of regiospecificity</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>108</volume>, <fpage>17649</fpage>&#x02013;<lpage>17654</lpage>.<pub-id pub-id-type="pmid">21987796</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Gerlt</surname><given-names>J. A.</given-names></name>; <name><surname>Babbitt</surname><given-names>P. C.</given-names></name> (<year>2000</year>) <article-title>Can sequence determine function?</article-title>. <source>Genome Biol.</source>
<volume>1</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">11178226</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Whisstock</surname><given-names>J. C.</given-names></name>; <name><surname>Lesk</surname><given-names>A. M.</given-names></name> (<year>2003</year>) <article-title>Prediction
of protein function from protein sequence
and structure</article-title>. <source>Q. Rev. Biophys.</source>
<volume>36</volume>, <fpage>307</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">15029827</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Schnoes</surname><given-names>A. M.</given-names></name>; <name><surname>Brown</surname><given-names>S. D.</given-names></name>; <name><surname>Dodevski</surname><given-names>I.</given-names></name>; <name><surname>Babbitt</surname><given-names>P. C.</given-names></name> (<year>2009</year>) <article-title>Annotation error
in public databases: Misannotation of molecular function in enzyme
superfamilies</article-title>. <source>PLoS Comput. Biol.</source>
<volume>5</volume>, <fpage>e1000605</fpage>.<pub-id pub-id-type="pmid">20011109</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Baker</surname><given-names>D.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name> (<year>2001</year>) <article-title>Protein structure prediction and structural genomics</article-title>. <source>Science</source>
<volume>294</volume>, <fpage>93</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">11588250</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Hermann</surname><given-names>J. C.</given-names></name>; <name><surname>Marti-Arbona</surname><given-names>R.</given-names></name>; <name><surname>Fedorov</surname><given-names>A. A.</given-names></name>; <name><surname>Fedorov</surname><given-names>E.</given-names></name>; <name><surname>Almo</surname><given-names>S. C.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name>; <name><surname>Raushel</surname><given-names>F. M.</given-names></name> (<year>2007</year>) <article-title>Structure-based activity prediction
for an enzyme of unknown function</article-title>. <source>Nature</source>
<volume>448</volume>, <fpage>775</fpage>&#x02013;<lpage>779</lpage>.<pub-id pub-id-type="pmid">17603473</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Guichou</surname><given-names>J.-F.</given-names></name>; <name><surname>Labesse</surname><given-names>G.</given-names></name> (<year>2012</year>) <article-title>Fragment and conquer:
From structure to complexes to
function</article-title>. <source>Structure</source>
<volume>20</volume>, <fpage>1617</fpage>&#x02013;<lpage>1619</lpage>.<pub-id pub-id-type="pmid">23063007</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Wright</surname><given-names>G. D.</given-names></name> (<year>2007</year>) <article-title>The antibiotic
resistome: The nexus of chemical and genetic diversity</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>5</volume>, <fpage>175</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">17277795</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Cundliffe</surname><given-names>E.</given-names></name>; <name><surname>Demain</surname><given-names>A. L.</given-names></name> (<year>2010</year>) <article-title>Avoidance of suicide in antibiotic-producing microbes</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source>
<volume>37</volume>, <fpage>643</fpage>&#x02013;<lpage>672</lpage>.<pub-id pub-id-type="pmid">20446033</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Allan</surname><given-names>C. M.</given-names></name>; <name><surname>Hill</surname><given-names>S.</given-names></name>; <name><surname>Morvaridi</surname><given-names>S.</given-names></name>; <name><surname>Saiki</surname><given-names>R.</given-names></name>; <name><surname>Johnson</surname><given-names>J. S.</given-names></name>; <name><surname>Liau</surname><given-names>W.-S.</given-names></name>; <name><surname>Hirano</surname><given-names>K.</given-names></name>; <name><surname>Kawashima</surname><given-names>T.</given-names></name>; <name><surname>Ji</surname><given-names>Z.</given-names></name>; <name><surname>Loo</surname><given-names>J. A.</given-names></name>; <name><surname>Shepherd</surname><given-names>J. N.</given-names></name>; <name><surname>Clarke</surname><given-names>C. F.</given-names></name> (<year>2013</year>) <article-title>A conserved START
domain coenzyme Q-binding polypeptide is required for efficient Q
biosynthesis, respiratory electron transport, and antioxidant function
in <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1831</volume>, <fpage>776</fpage>&#x02013;<lpage>791</lpage>.<pub-id pub-id-type="pmid">23270816</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Baker</surname><given-names>J. R.</given-names></name>; <name><surname>Woolfson</surname><given-names>D. N.</given-names></name>; <name><surname>Muskett</surname><given-names>F. W.</given-names></name>; <name><surname>Stoneman</surname><given-names>R. G.</given-names></name>; <name><surname>Urbaniak</surname><given-names>M. D.</given-names></name>; <name><surname>Caddick</surname><given-names>S.</given-names></name> (<year>2007</year>) <article-title>Protein&#x02013;small molecule interactions in neocarzinostatin,
the prototypical enediyne chromoprotein antibiotic</article-title>. <source>ChemBioChem</source>
<volume>8</volume>, <fpage>704</fpage>&#x02013;<lpage>717</lpage>.<pub-id pub-id-type="pmid">17451164</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Weigel</surname><given-names>L. M.</given-names></name>; <name><surname>Clewell</surname><given-names>D. B.</given-names></name>; <name><surname>Gill</surname><given-names>S. R.</given-names></name>; <name><surname>Clark</surname><given-names>N. C.</given-names></name>; <name><surname>McDougal</surname><given-names>L. K.</given-names></name>; <name><surname>Flannagan</surname><given-names>S. E.</given-names></name>; <name><surname>Kolonay</surname><given-names>J. F.</given-names></name>; <name><surname>Shetty</surname><given-names>J.</given-names></name>; <name><surname>Killgore</surname><given-names>G. E.</given-names></name>; <name><surname>Tenover</surname><given-names>F. C.</given-names></name> (<year>2003</year>) <article-title>Genetic analysis of a high-level vancomycin-resistant
isolate of <italic>Staphylococcus aureus</italic></article-title>. <source>Science</source>
<volume>302</volume>, <fpage>1569</fpage>&#x02013;<lpage>1571</lpage>.<pub-id pub-id-type="pmid">14645850</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Qureshi</surname><given-names>N. K.</given-names></name>; <name><surname>Yin</surname><given-names>S.</given-names></name>; <name><surname>Boyle-Vavra</surname><given-names>S.</given-names></name> (<year>2014</year>) <article-title>The role of the Staphylococcal VraTSR regulatory system
on vancomycin resistance and vanA operon expression in vancomycin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>PloS One</source>
<volume>9</volume>, <fpage>e85873</fpage>.<pub-id pub-id-type="pmid">24454941</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="computer-program" id="cit58"><source>The PyMOL Molecular Graphics System</source>, Version
1.3r1.
(<year>2010</year>, August) <publisher-name>Schr&#x000f6;dinger, LLC.</publisher-name>, <publisher-loc>New York</publisher-loc>.</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Kearse</surname><given-names>M.</given-names></name>; <name><surname>Moir</surname><given-names>R.</given-names></name>; <name><surname>Wilson</surname><given-names>A.</given-names></name>; <name><surname>Stones-Havas</surname><given-names>S.</given-names></name>; <name><surname>Cheung</surname><given-names>M.</given-names></name>; <name><surname>Sturrock</surname><given-names>S.</given-names></name>; <name><surname>Buxton</surname><given-names>S.</given-names></name>; <name><surname>Cooper</surname><given-names>A.</given-names></name>; <name><surname>Markowitz</surname><given-names>S.</given-names></name>; <name><surname>Duran</surname><given-names>C.</given-names></name>; <name><surname>Thierer</surname><given-names>T.</given-names></name>; <name><surname>Ashton</surname><given-names>B.</given-names></name>; <name><surname>Meintjes</surname><given-names>P.</given-names></name>; <name><surname>Drummond</surname><given-names>A.</given-names></name> (<year>2012</year>) <article-title>Geneious Basic: An integrated and
extendable desktop software platform for the organization and analysis
of sequence data</article-title>. <source>Bioinformatics</source>
<volume>28</volume>, <fpage>1647</fpage>&#x02013;<lpage>1649</lpage>.<pub-id pub-id-type="pmid">22543367</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Acton</surname><given-names>T. B.</given-names></name>; <name><surname>Xiao</surname><given-names>R.</given-names></name>; <name><surname>Anderson</surname><given-names>S.</given-names></name>; <name><surname>Aramini</surname><given-names>J.</given-names></name>; <name><surname>Buchwald</surname><given-names>W. A.</given-names></name>; <name><surname>Ciccosanti</surname><given-names>C.</given-names></name>; <name><surname>Conover</surname><given-names>K.</given-names></name>; <name><surname>Everett</surname><given-names>J.</given-names></name>; <name><surname>Hamilton</surname><given-names>K.</given-names></name>; <name><surname>Huang</surname><given-names>Y. J.</given-names></name>; <name><surname>Janjua</surname><given-names>H.</given-names></name>; <name><surname>Kornhaber</surname><given-names>G.</given-names></name>; <name><surname>Lau</surname><given-names>J.</given-names></name>; <name><surname>Lee</surname><given-names>D. Y.</given-names></name>; <name><surname>Liu</surname><given-names>G.</given-names></name>; <name><surname>Maglaqui</surname><given-names>M.</given-names></name>; <name><surname>Ma</surname><given-names>L.</given-names></name>; <name><surname>Mao</surname><given-names>L.</given-names></name>; <name><surname>Patel</surname><given-names>D.</given-names></name>; <name><surname>Rossi</surname><given-names>P.</given-names></name>; <name><surname>Sahdev</surname><given-names>S.</given-names></name>; <name><surname>Shastry</surname><given-names>R.</given-names></name>; <name><surname>Swapna</surname><given-names>G. V. T.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>; <name><surname>Tong</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Zhao</surname><given-names>L.</given-names></name>; <name><surname>Montelione</surname><given-names>G. T.</given-names></name> (<year>2011</year>) <article-title>Preparation
of protein samples for NMR structure, function, and small-molecule
screening studies</article-title>. <source>Methods Enzymol.</source>
<volume>493</volume>, <fpage>21</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">21371586</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Xiao</surname><given-names>R.</given-names></name>; <name><surname>Anderson</surname><given-names>S.</given-names></name>; <name><surname>Aramini</surname><given-names>J.</given-names></name>; <name><surname>Belote</surname><given-names>R.</given-names></name>; <name><surname>Buchwald</surname><given-names>W. A.</given-names></name>; <name><surname>Ciccosanti</surname><given-names>C.</given-names></name>; <name><surname>Conover</surname><given-names>K.</given-names></name>; <name><surname>Everett</surname><given-names>J. K.</given-names></name>; <name><surname>Hamilton</surname><given-names>K.</given-names></name>; <name><surname>Huang</surname><given-names>Y. J.</given-names></name>; <name><surname>Janjua</surname><given-names>H.</given-names></name>; <name><surname>Jiang</surname><given-names>M.</given-names></name>; <name><surname>Kornhaber</surname><given-names>G. J.</given-names></name>; <name><surname>Lee</surname><given-names>D. Y.</given-names></name>; <name><surname>Locke</surname><given-names>J. Y.</given-names></name>; <name><surname>Ma</surname><given-names>L.-C.</given-names></name>; <name><surname>Maglaqui</surname><given-names>M.</given-names></name>; <name><surname>Mao</surname><given-names>L.</given-names></name>; <name><surname>Mitra</surname><given-names>S.</given-names></name>; <name><surname>Patel</surname><given-names>D.</given-names></name>; <name><surname>Rossi</surname><given-names>P.</given-names></name>; <name><surname>Sahdev</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>S.</given-names></name>; <name><surname>Shastry</surname><given-names>R.</given-names></name>; <name><surname>Swapna</surname><given-names>G. V. T.</given-names></name>; <name><surname>Tong</surname><given-names>S. N.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Zhao</surname><given-names>L.</given-names></name>; <name><surname>Montelione</surname><given-names>G. T.</given-names></name>; <name><surname>Acton</surname><given-names>T. B.</given-names></name> (<year>2010</year>) <article-title>The high-throughput protein sample production platform
of the Northeast Structural Genomics Consortium</article-title>. <source>J. Struct. Biol.</source>
<volume>172</volume>, <fpage>21</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">20688167</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Luft</surname><given-names>J. R.</given-names></name>; <name><surname>Wolfley</surname><given-names>J. R.</given-names></name>; <name><surname>Said</surname><given-names>M. I.</given-names></name>; <name><surname>Nagel</surname><given-names>R. M.</given-names></name>; <name><surname>Lauricella</surname><given-names>A. M.</given-names></name>; <name><surname>Smith</surname><given-names>J. L.</given-names></name>; <name><surname>Thayer</surname><given-names>M. H.</given-names></name>; <name><surname>Veatch</surname><given-names>C. K.</given-names></name>; <name><surname>Snell</surname><given-names>E. H.</given-names></name>; <name><surname>Malkowski</surname><given-names>M. G.</given-names></name>; <name><surname>Detitta</surname><given-names>G. T.</given-names></name> (<year>2007</year>) <article-title>Efficient optimization of crystallization
conditions by manipulation of drop volume ratio and temperature</article-title>. <source>Protein Sci. Publ. Protein Soc.</source>
<volume>16</volume>, <fpage>715</fpage>&#x02013;<lpage>722</lpage>.</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Otwinowski</surname><given-names>Z.</given-names></name>; <name><surname>Minor</surname><given-names>W.</given-names></name> (<year>1997</year>) <article-title>Processing of X-ray diffraction data
collected in oscillation mode</article-title>. <source>Methods Enzymol.</source>
<volume>276</volume>, <fpage>307</fpage>&#x02013;<lpage>326</lpage>.</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Sheldrick</surname><given-names>G. M.</given-names></name> (<year>2010</year>) <article-title>Experimental
phasing with SHELXC/D/E: Combining chain tracing with density modification</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>479</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">20383001</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Berendzen</surname><given-names>J.</given-names></name> (<year>1999</year>) <article-title>Automated
MAD and MIR structure solution</article-title>. <source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<volume>55</volume>, <fpage>849</fpage>&#x02013;<lpage>861</lpage>.<pub-id pub-id-type="pmid">10089316</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Lohkamp</surname><given-names>B.</given-names></name>; <name><surname>Scott</surname><given-names>W. G.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name> (<year>2010</year>) <article-title>Features and development
of Coot</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>486</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Murshudov</surname><given-names>G. N.</given-names></name>; <name><surname>Vagin</surname><given-names>A. A.</given-names></name>; <name><surname>Dodson</surname><given-names>E. J.</given-names></name> (<year>1997</year>) <article-title>Refinement
of macromolecular structures
by the maximum-likelihood method</article-title>. <source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<volume>53</volume>, <fpage>240</fpage>&#x02013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">15299926</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Laskowski</surname><given-names>R.</given-names></name>; <name><surname>MacArthur</surname><given-names>M.</given-names></name>; <name><surname>Moss</surname><given-names>D.</given-names></name>; <name><surname>Thornton</surname><given-names>J.</given-names></name> (<year>1993</year>) <article-title>PROCHECK: A program
to check the stereochemical quality of protein structures</article-title>. <source>J. Appl. Crystallogr.</source>
<volume>26</volume>, <fpage>283</fpage>&#x02013;<lpage>291</lpage>.</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Shi</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zeng</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Deng</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Kang</surname><given-names>T.</given-names></name>; <name><surname>Tao</surname><given-names>M.</given-names></name>; <name><surname>Rusinova</surname><given-names>E.</given-names></name>; <name><surname>Zhang</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Zhu</surname><given-names>H.</given-names></name>; <name><surname>Yao</surname><given-names>J.</given-names></name>; <name><surname>Zeng</surname><given-names>Y.-X.</given-names></name>; <name><surname>Evers</surname><given-names>B. M.</given-names></name>; <name><surname>Zhou</surname><given-names>M.-M.</given-names></name>; <name><surname>Zhou</surname><given-names>B. P.</given-names></name> (<year>2014</year>) <article-title>Disrupting
the interaction of BRD4 with diacetylated twist suppresses tumorigenesis
in basal-like breast cancer</article-title>. <source>Cancer Cell</source>
<volume>25</volume>, <fpage>210</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">24525235</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Zhai</surname><given-names>J.</given-names></name>; <name><surname>Str&#x000f6;m</surname><given-names>A.-L.</given-names></name>; <name><surname>Kilty</surname><given-names>R.</given-names></name>; <name><surname>Venkatakrishnan</surname><given-names>P.</given-names></name>; <name><surname>White</surname><given-names>J.</given-names></name>; <name><surname>Everson</surname><given-names>W. V.</given-names></name>; <name><surname>Smart</surname><given-names>E. J.</given-names></name>; <name><surname>Zhu</surname><given-names>H.</given-names></name> (<year>2009</year>) <article-title>Proteomic
characterization of lipid raft proteins in amyotrophic lateral sclerosis
mouse spinal cord</article-title>. <source>FEBS J.</source>
<volume>276</volume>, <fpage>3308</fpage>&#x02013;<lpage>3323</lpage>.<pub-id pub-id-type="pmid">19438725</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Chen</surname><given-names>V. B.</given-names></name>; <name><surname>Arendall</surname><given-names>W. B.</given-names><suffix>3rd</suffix></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Keedy</surname><given-names>D. A.</given-names></name>; <name><surname>Immormino</surname><given-names>R. M.</given-names></name>; <name><surname>Kapral</surname><given-names>G. J.</given-names></name>; <name><surname>Murray</surname><given-names>L. W.</given-names></name>; <name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name> (<year>2010</year>) <article-title>MolProbity: All-atom structure validation
for macromolecular
crystallography</article-title>. <source>Acta Crystallogr., Sect. D:
Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>12</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">20057044</pub-id></mixed-citation></ref></ref-list></back></article>